header logo image


Page 930«..1020..929930931932..940950..»

Stem Cell Treatment: Costa Rica vs Panama

June 27th, 2018 4:47 am

We have received several inquiries about the stem cell clinic that was previously in Costa Rica, but moved to Panama, and is now known as the Stem Cell Institute of Panama.People were curious about the circumstances surrounding their move, and how the stem cell treatment at our clinic differ in terms of procedures, price, and efficacy?

Why did Stem Cell Institute Panama move? Is the health care system better in Panama? What Happened?

First, it is important to mention that when the Stem Cell Institute of Panama moved from Costa Rica to Panama, stem cell treatment laws were being modified in Costa Rica and stem cell treatments were not legally approved by the Costa Rican Government at that time, a situation that has changed today.

In 2010, Ileana Herrera, the head of the health ministrys research council in Costa Rica, said the Stem Cell Institute of Panama, which opened in Costa Rica in 2006, would be allowed to store adult stem cells extracted from patients own fat tissue, bone marrow and donated umbilical cords, but not perform treatments since efficiency and safety were uncertain.

Today stem cell treatments in Costa Rica are legally approved and promoted by relevant medical clinics like the Stem Cells Transplant Institute in Escaz. Regulations in Costa Rica were modified recently in favor of the use of stem cells. The complaints by Stem Cell Institute of Panama originated due to the situation in Costa Rica at that specific time. Research into the type of comments and complaints in searches related to the Panamanian company would reveal inquiries such as:

Many articles have been written in response to the above questions by various sources with statements both pro and con, but those comments, and / or complaints would be made about any clinic anywhere because of the controversy surrounding these new stem cell treatments.

The Stem Cell Transplants Institute in Panama, as well as the healthcare system, faces many challenges today that interfere with complete development.

Despite advances in stem cells transplants in Panama and in Panamas health care in the past few years, there is a shortage of healthcare professionals. This is not an issue limited to the health sector, but rather a tendency that affects multiple fields of the economy in Panama. Also, although the country has made important advances toward universal healthcare coverage, according to the Pan American Health Organization, public and private sector covered around 90% of the population in 2014, access to health services is not equally available for everyone. There is a marked discrepancy between health outcomes in urban and rural settings.

In comparison, the Costa Rican healthcare system is rated very highly on an international level, and the countrys citizens enjoy the health and life expectancy equal to that of more developed nations. Nearly the entire population of Costa Rica had healthcare coverage by the year 2006. In addition, the country ranks among one of the best for specialized medical professionals. This is the case with Dr. Leslie Mesn, who specializes in stem cells treatments and anti-aging therapies in Escaz.Get more information here.

To summarize, the healthcare in Costa Rica has many advantages when compared to Panama. Additional benefits include, security and weather. For example, Panama is more hot, humid, and cloudy and has a prolonged rainy season. Costa Rica is a great destination for stem cell therapy.

How do our treatments differ? Are Stem Cells Institute Panama cures and methods different from ours?

The Stem Cell Institute of Panama utilizes mainly combinations of allogeneic human umbilical cord stem cells and autologous bone marrow stem cells to treat the diseases. The Stem Cells Institute in Costa Rica uses adult autologous stem cells obtained from the patients own fatty tissue.

Allogeneic stem cell transplantation utilized by Stem Cell Institute of Panama is a procedure in which a person receives stem cells from a genetically similar, but not identical, donor. These types of cells are more vulnerable to rejection than autologous cells (cells derived from the same individual). In comparison, the Stem Cells Transplant Institute in Costa Rica uses exclusively adult autologous stem cells obtained from the patients own tissue, so risk of rejections is almost non-existent. Adult stem cells are less likely to be rejected when used in transplants and they are possible to reprogram. The success of using adult stem cells has been demonstrated in various clinical applications. Top stem cell research universities have studies suggesting that adult stem cells may have greater plasticity than was originally thought, which means that they may be able to differentiate into a greater range of specialized cell types. At present, however, it would appear that embryonic stem cells still have the advantage in their ability to differentiate more readily than adult stem cells, but as we just mentioned, the possibility of rejection is also much higher.

Another important difference between the Stem Cell Institute of Panama treatments and the treatments at the Stem Cells Transplant Institute of Costa Rica is that since adult stem cells are derived from adult tissues and, of course, with consent from the patient, there is little if any ethical dilemma to adult stem cell therapies. Embryonic stem cells and umbilical cord stem cells, on the other hand, have triggered enormous debate due to the destruction of an embryo following cell extraction or issues surrounding the collection and application of stem cells from the umbilical cord.

At the Stem Cells Transplant Institute in Costa Rica, we use adult stem cells. We harvest stem cells from a sample of your own bone marrow or adipose tissue and later inject them intravenously or directly in the zone required. The therapies are legally approved in Costa Rica and are highly controlled. You can be assured that we follow the highest ethical standards and do not practice any procedures that may be viewed as crossing the ethical standards of human life.

Are therapies more expensive in Costa Rica? Are Stem Cell Institute Panama costs lower?

No, the cost of treatment at the Stem Cell Institute of Panama is very similar to Costa Rica. The experts at the Stem Cells Institute in Costa Rica use state-of-the-art technology and provide high quality care at a reasonable price.

Do treatments in Costa Rica differ from the treatments at the Stem Cell Institute of Panama in terms of efficacy?

Stem cell transplants in Panama and Costa Rica are being used for autism, COPD, anti-aging and many other degenerative and inflammatory diseases. People with various illnesses interested in stem cell treatment at the Stem Cell Institute of Panama, have done an internet search for:

It should be noted that the Stem Cells Transplant Institute of Costa Rica offers the same treatments, and more in our new, ultra-modern clinic in the CIMA Medical Center. In terms of efficacy, stem cells by themselves have the remarkable potential to develop into many different cell types in the body independently of the health center; however, it requires a strict isolation process and qualified expertise for the correct application.

At the Stem Cells Transplant Institute in Costa Rica, we guarantee you we strictly follow well-designed isolation protocols, with high standards of quality, hygiene, and top technological resources. The therapies are applied by highly qualified professionals so you receive the best possible results. The procedures followed by Stem Cell Transplant Institute of Panama are not known to us.

The Stem Cell Institute of Panama moved from Costa Rica because of temporary circumstances that have been resolved and have nothing to do with aspects of efficacy, lower costs or lack of resources in Costa Rica. In comparison, Costa Rica has a higher standard of healthcare and expert institutions like the Stem Cells Transplant Institute that offer legally approved and high-quality therapies.

Read the original post:
Stem Cell Treatment: Costa Rica vs Panama

Read More...

Ethical and legal issues and the "new genetics" | The …

June 27th, 2018 4:47 am

In recent years there has been an explosion of knowledge in the science of genetics but often less general awareness of the ethical and legal implications of genetic advances. Fueled by sensationalist media reporting, developments are often exaggerated and create unrealistic expectations for the "new genetics".1 Medicine has a great capacity to test and screen for gene mutations, but currently little ability to cure the clinical consequences of these mutations. Because of the newness of this information, and the deterministic way in which many interpret the data, there is a risk that predictive genetic information will be misunderstood and too much weight will be placed on it.1 Genetic determinism is particularly unwelcome, because most common diseases involve the interaction of predisposing genes with a facilitative environment the value of genetic knowledge is usually to allow accurate environmental or pharmacological intervention.

Concerns have been raised about the misuse of genetic information, particularly with computerisation and linkage of health records.2 These concerns may reduce the willingness of individuals to undergo genetic testing, even when the tests are clearly beneficial. In a recent initiative in Victoria, only a small proportion of people offered free gene screening for haemochromatosis accepted the test. One can only speculate as to the reasons for this low uptake, but fears about confidentiality and potential misuse of the information may have played some part.3,4 This was in spite of the fact that the clinical consequences of haemochromatosis can be completely averted if appropriate action is taken. Furthermore, a unique agreement had been reached with the Investment Financial Services Association (IFSA), the peak body of the life insurance industry in Australia, that people who tested positive for haemochromatosis and agreed to take preventive measures (regular blood donation) would not be refused life insurance or have their premiums loaded because of their genetic status.5

In many cases, ethical concerns about genetics simply underscore existing concerns about marginalisation, stigmatisation and discrimination of disadvantaged groups. Although these concerns may be valid, they are not new or unique to genetics. However, the sheer scope of genetics and the complex nature of genetic information, extending beyond individuals, mean that these concerns are now more pressing. There are also some significant new ethical and legal issues emerging from the application of the human genome project to medicine, particularly with regard to predictive information about common diseases and for traits (such as criminality or ability) that are not diseases at all.

Our aim in this article is to give a broad overview of the main ethical and legal challenges presented by the new genetics and their implications for the medical profession. In many instances, these issues have not been resolved and the full debate remains to be had. Typically, there are no easy answers to the dilemmas raised, but awareness of what the key issues are and sketching of directions will help healthcare professionals understand and participate in these developments.

Some basic principles to keep in mind when considering ethics are presented in Box 1. In Australia, ethics usually revolves around informed choices by individuals. However, the pervasive and predictive nature of genetic information means that every clinician has to be familiar not only with its clinical significance, but also the ethical implications.7 As well as thinking of patients as individuals, doctors must think of families, because gene analyses affect parents, siblings, children, the unborn, and sometimes entire ethnic groups. Doctors must be aware that this responsibility to family may conflict with the individual's right to privacy.

There are some fairly straightforward ethical issues that arise with respect to genetics:

Is the application of genetics lawful? If it is not, it cannot be offered, as is the case for using DNA to select the sex of an embryo in Victoria, except to avoid transmission of a genetic disorder.8 Even if it is lawful, do you, as a doctor have an ethical objection to this test or procedure, such that you would have to advise the patient to see another doctor?

Is it safe? If it can cause harm, is the likely harm balanced by the likely benefit?

Is it helpful in dealing with the problems you perceive as relevant to this patient, this family? Is it helpful in dealing with the problems as perceived by them?

Is it evidence-based, or still a research procedure?

Is it cost-effective?

These types of issues arise with every medical procedure, but arise with an unprecedented intensity for genetics.

The availability of genetic testing offers the "capacity to know" about one's genetic destiny with greater certainty than revealed by family history alone, but knowledge will not always be welcome and individuals are generally at liberty to decide whether they want this information. The ethics of testing are different if action can be taken to prevent or treat a disease, as for haemochromatosis, as compared with conditions for which no treatments are presently available, such as Huntington disease. If prevention or early treatment is available, it is unethical not to offer testing. However, some people want and use knowledge even if there is no treatment, for example, for reproductive choice. Particular care needs to be taken with the predictive genetic testing of children: this is widely regarded as inappropriate unless preventive strategies are available.9,10

The capacity to use test data for reproductive choice brings a range of ethical dilemmas. Genetic testing of fetuses with a view to termination of pregnancy is met with alarm by some disability advocates, who are concerned about approaches that treat disability as a "problem" that should be prevented using genetic means, rather than dealing with the issue of non-discrimination of people with disabilities.11 Concerns have been expressed that the range of conditions that may be tested for will extend to good looks and abilities, leading to fears of "designer babies" and the spectre of eugenics.

Society will set the limits within which choices will be made. Although there is some disquiet about genetic interventions, as a society we need to ensure that we have a balanced ethical debate on issues of concern and that we distil the real ethical issues. The challenge ahead is to ensure that the newness of genetics does not unreasonably impede its implementation. There may be a natural resistance to the expansion of genetic science and technology, particularly where it extends beyond the therapeutic model (eg, to enhance appearance or intelligence), but it is important that we not limit the available options unless there is sound justification for doing so. This also underscores the importance of offering appropriate genetic counselling, particularly for the more complex situations in predictive or prenatal testing, so that individuals can make informed choices in both an individual and a social context.

The law needs to set limits within which scientific development and clinical practice can operate. Although the scope and extent of protection that should be provided by the law is a matter for debate, there is consensus that the law should protect individuals from avoidable harm.

The metaphor of the law "limping in the rear" of the march of science12 is often invoked, and nowhere more so than in the context of the new genetics. There are few laws in Australia regulating the collection and use of personal genetic information, and none that do so explicitly for genetic information. The present legal framework in this area consists primarily of anti-discrimination and privacy legislation. We end up with a complex legislative patchwork, which has some influence on the permissible collection and use of personal human genetic information, but does not effectively "regulate" it. For this reason, there has been much agitation for reform to respond to the new challenges created by the increase in the range of available genetic testing.

The collection and use of human genetic information, and the measures that may be necessary to protect the individual are under intense scrutiny by the Australian Law Reform Commission (ALRC) and the Australian Health Ethics Committee (AHEC).13 A discussion paper released in August 2002 canvasses a range of issues and makes numerous proposals for regulation.14 These are being finalised for public discussion and possible enactment.

The availability of the new genetics has implications with regard to doctors' legal duty of care to their patients. Doctors have a responsibility to keep up to date with the new genetics so that they can give advice on what tests are available. As with any medical procedure, the law protects the autonomy of competent individuals to decide whether to undergo genetic testing and to accept medical treatment or advice about lifestyle changes arising from such testing. However, there are tensions between the rights of individuals and the rights of the family, for whom this information may have relevance to health. Privacy regulation in Australia comprises a combination of common law and legislation.15 At present, no special status is afforded to genetic information. Strictly, even taking a person's family history involves a potential breach of the privacy of other family members. This difficulty has now been addressed through the Federal Privacy Commissioner making a Public Interest Determination to cover family medical histories.16

Problems can also arise with the disclosure of an individual's genetic information to other family members. At present, standard rules regarding the disclosure of health information apply, limiting disclosure to circumstances where there is a threat of serious and imminent harm to others or a serious public health risk.17 However, the familial nature of genetic information demands some modification of the usual principles of privacy and non-disclosure, in both directions. The information should be able to be shared with family members whose health may benefit from access to this information by alerting them to the risk of genetic disease and enabling them to institute preventive or therapeutic strategies,18 but be protected more carefully from outsiders. One aspect of the ALRC/AHEC proposals that is likely to be of practical relevance to doctors is the proposal to expand the circumstances in which genetic information may be released to other family members.14

There are also vexing questions about whether third parties should be entitled to access personal genetic information. When applying for insurance, individuals are required to disclose family history and the results of any genetic tests,19 and insurers are entitled to take this information into account for the purposes of underwriting for life insurance and related products. Insurers are exempt from disability discrimination,20 but must be able to justify the way in which they use the genetic information with regard to actuarial, statistical or other data. There are concerns about the adequacy of available data for underwriting purposes and the potential for unfair genetic discrimination (Box 2).22 In several jurisdictions, including the United Kingdom, moratoriums have been introduced on the use of genetic test information by insurers, or such use has been prohibited by legislation. Current proposals for reform put forward by the ALRC/AHEC retain the insurers' entitlement to use genetic test information for risk assessment, but seek to regulate more stringently what genetic tests can be used by devolving this responsibility to the proposed Human Genetics Commission of Australia.14

In the sphere of employment, the challenge is to ensure that legitimate uses of genetic test information are permitted, such as offering screening for susceptibility to workplace hazards that cannot otherwise be avoided, but to protect employees and job seekers from unfair discrimination motivated by employers' expediency and profit. The proposals advanced by the ALRC/AHEC seek to strike a proper balance to allow uses of genetic testing which are consistent with occupational health and safety interests, but prohibit other uses.14

Fundamental questions are also being raised about the status of genetic samples collected for pathology examination, such as blood or other sources of DNA, including pathological tissue blocks and human tissue on microscope slides. At present, these are generally regarded as the property of the hospital, over which the donor may have no legally enforceable rights. Although such samples have no clear legal status as property, opinions are divided over whether it is appropriate to create legally enforceable rights, especially if the sample proves to have a commercial value.23,24 The line between research and clinical care is ethically blurred when a sample is studied by a specialist or a pathologist, and becomes even more confusing as we move towards an increasingly commercialised environment in which the potential for profit from genetic knowledge is real and the clamour for patents resonates.25

When it comes to regulation of artificial reproductive technology, the situation is even more confused. In Victoria, South Australia and Western Australia, there is legislation regulating this area.26-28 These Acts, to varying degrees, restrict the circumstances in which genetic testing can be undertaken. The other States and Territories have no legislation, and this lack of uniformity invites "doctor shopping".29

There is great concern that genetics will be used for "designer babies", but no one knows whether this will be possible, economically viable, or wanted by anyone. Couples are now being allowed to choose pregnancies that will provide an infant with a particular genetic make-up in the context of a sibling with a very serious illness.30 The baby can then be a donor of cord blood stem cells to the seriously ill sibling. Although this is occasionally described as "designer babies", it is clearly far from what concerns the public. It is important for doctors to be aware of and emphasise the difference between the use of clinical interventions to save the lives of children with serious diseases, as compared with the use of procedures for trivial purposes such as choosing hair or eye colour. The former is generally thought to be ethical, the latter unethical. There is concern that over-the-counter DNA tests will soon be available, but knowledge has for generations been regarded as a positive, not a negative, commodity. Doctors may be the gatekeepers of the new genetic knowledge, but they will not be its owners.

The draft sequence of the human genome is now on the Web, and advances in our understanding of the relationships between genes and environment and disease occur almost daily. Challenging issues lie on the horizon in terms of defining the role of doctors with respect to their patients and the extent of their duty of care, as we learn more of the relationship between genes, the environment and complex diseases and behaviours. Because of community concerns, there will be pressure for laws to regulate the application of genetics in medicine. However, knowledge of genetics and the methods of applying it to people are changing rapidly, so there is an overwhelming need for flexibility in the development of solutions. This may encourage the use of regulations and other "soft" laws, such as guidelines and codes of practice, in preference to statute law, as the former are easier to adapt to new situations.

The new genetics has enormous potential to confer clinical benefits. The challenge is to harness these benefits and to minimise the risk of harm. Fortunately, most doctors, patients and families want to make sensible choices. The ethical interpretations we offer, and the legal framework that is used to interpret these ethical principles, must ensure that application of the new genetics is not unreasonably restricted as it develops. The better informed doctors are of the ethical and legal issues arising from the new genetics, the better equipped they will be to give appropriate information to patients and the community.

1: Ethical principles

There are many religions and belief systems, and it is important that healthcare ethics should be able to inform decisions of the whole community. Four principles that could underpin an ethical approach to healthcare issues are: 6

1. Respect autonomy: educate, communicate, consult, respect and empower. (Autonomy is both very important and controversial in genetics. Conflict between the rights of the individual, the family and the community arise more often for genetic issues than for most medical procedures.)

2. Beneficence: provide net benefits, but ensure these are realistic.

3. Non-maleficence: do no avoidable harm, to individuals or groups.

4. Promote justice: fair distribution of resources, respect for rights and respect for morally acceptable laws. (One problem of genetics is that it "is not fair". We are not "created equal", because our genetics differs, and with it our health risks. However, the doctor has to try to create a level playing field, in the interests of justice.)

When applied in the context of genetics, beneficence and non-maleficence sit easily, but, for the reasons noted above, autonomy and justice are problematic.

2: Genetic discrimination

Genetic discrimination can be defined as different treatment of an individual by a third party such as an insurer or employer on the basis of genetic factors real, inferred or wrongly imputed. Discrimination can be positive or negative: the concerns relate to unfavourable discrimination, involving decisions adverse to the interests of the individuals involved. Unfavourable discrimination can be justifiable and lawful: anti-discrimination legislation, which provides protection for some forms of unfair discrimination, contains exemptions from discrimination by insurers and employers in some circumstances.

A team of researchers, funded by the Australian Research Council, is conducting a major empirical study into the nature and extent of genetic discrimination in Australia and its social and legal implications.21 The study seeks to gain the experience and perspective of all key stakeholders: "consumers" (those considered to be at risk because of a genetic test result or their family history); third parties such as insurers and employers (the groups against which allegations of genetic discrimination have most frequently been made); and the various organisations within the legal system through which complaints of alleged genetic discrimination may be pursued.

Read more:
Ethical and legal issues and the "new genetics" | The ...

Read More...

NJVMA | New Jersey Veterinary Medical Association

June 26th, 2018 8:46 am

The New Jersey Veterinary Medical Association (NJVMA) Animal Hall of Fame Committee has selected two dogs, one rabbit, one horse and an animal sanctuary for induction into the 23rd Annual NJVMA Animal Hall of Fame.

The NJVMA is honored to recognize the animals and people that inspired us to share their stories and to recognize the role that veterinarians play in strengthening the human-animal bond, said Dr. Peter Falk, Chair of the Animal Hall of Fame Committee. This years exceptional inductees have made significant contributions to those around them.

A forever home for unwanted animals, a retired service dog, a floppy-eared snuggle bunny, an intuitive therapy horse and working police Bloodhound will be celebrated on March 11, 2018 with induction into the NJVMA Animal Hall of Fame.

Because of the internet and social media, stories involving the human-animal bond now reach well beyond state and even national boundaries and have the potential to prompt action on a global scale, Dr. Falk said.

Read more

Follow this link:
NJVMA | New Jersey Veterinary Medical Association

Read More...

biotechnology | Definition, Examples, & Applications …

June 26th, 2018 8:46 am

Biotechnology, the use of biology to solve problems and make useful products. The most prominent area of biotechnology is the production of therapeutic proteins and other drugs through genetic engineering.

People have been harnessing biological processes to improve their quality of life for some 10,000 years, beginning with the first agricultural communities. Approximately 6,000 years ago, humans began to tap the biological processes of microorganisms in order to make bread, alcoholic beverages, and cheese and to preserve dairy products. But such processes are not what is meant today by biotechnology, a term first widely applied to the molecular and cellular technologies that began to emerge in the 1960s and 70s. A fledgling biotech industry began to coalesce in the mid- to late 1970s, led by Genentech, a pharmaceutical company established in 1976 by Robert A. Swanson and Herbert W. Boyer to commercialize the recombinant DNA technology pioneered by Boyer and Stanley N. Cohen. Early companies such as Genentech, Amgen, Biogen, Cetus, and Genex began by manufacturing genetically engineered substances primarily for medical and environmental uses.

For more than a decade, the biotechnology industry was dominated by recombinant DNA technology, or genetic engineering. This technique consists of splicing the gene for a useful protein (often a human protein) into production cellssuch as yeast, bacteria, or mammalian cells in culturewhich then begin to produce the protein in volume. In the process of splicing a gene into a production cell, a new organism is created. At first, biotechnology investors and researchers were uncertain about whether the courts would permit them to acquire patents on organisms; after all, patents were not allowed on new organisms that happened to be discovered and identified in nature. But, in 1980, the U.S. Supreme Court, in the case of Diamond v. Chakrabarty, resolved the matter by ruling that a live human-made microorganism is patentable subject matter. This decision spawned a wave of new biotechnology firms and the infant industrys first investment boom. In 1982 recombinant insulin became the first product made through genetic engineering to secure approval from the U.S. Food and Drug Administration (FDA). Since then, dozens of genetically engineered protein medications have been commercialized around the world, including recombinant versions of growth hormone, clotting factors, proteins for stimulating the production of red and white blood cells, interferons, and clot-dissolving agents.

In the early years, the main achievement of biotechnology was the ability to produce naturally occurring therapeutic molecules in larger quantities than could be derived from conventional sources such as plasma, animal organs, and human cadavers. Recombinant proteins are also less likely to be contaminated with pathogens or to provoke allergic reactions. Today, biotechnology researchers seek to discover the root molecular causes of disease and to intervene precisely at that level. Sometimes this means producing therapeutic proteins that augment the bodys own supplies or that make up for genetic deficiencies, as in the first generation of biotech medications. (Gene therapyinsertion of genes encoding a needed protein into a patients body or cellsis a related approach.) But the biotechnology industry has also expanded its research into the development of traditional pharmaceuticals and monoclonal antibodies that stop the progress of a disease. Such steps are uncovered through painstaking study of genes (genomics), the proteins that they encode (proteomics), and the larger biological pathways in which they act.

In addition to the tools mentioned above, biotechnology also involves merging biological information with computer technology (bioinformatics), exploring the use of microscopic equipment that can enter the human body (nanotechnology), and possibly applying techniques of stem cell research and cloning to replace dead or defective cells and tissues (regenerative medicine). Companies and academic laboratories integrate these disparate technologies in an effort to analyze downward into molecules and also to synthesize upward from molecular biology toward chemical pathways, tissues, and organs.

In addition to being used in health care, biotechnology has proved helpful in refining industrial processes through the discovery and production of biological enzymes that spark chemical reactions (catalysts); for environmental cleanup, with enzymes that digest contaminants into harmless chemicals and then die after consuming the available food supply; and in agricultural production through genetic engineering.

Agricultural applications of biotechnology have proved the most controversial. Some activists and consumer groups have called for bans on genetically modified organisms (GMOs) or for labeling laws to inform consumers of the growing presence of GMOs in the food supply. In the United States, the introduction of GMOs into agriculture began in 1993, when the FDA approved bovine somatotropin (BST), a growth hormone that boosts milk production in dairy cows. The next year, the FDA approved the first genetically modified whole food, a tomato engineered for a longer shelf life. Since then, regulatory approval in the United States, Europe, and elsewhere has been won by dozens of agricultural GMOs, including crops that produce their own pesticides and crops that survive the application of specific herbicides used to kill weeds. Studies by the United Nations, the U.S. National Academy of Sciences, the European Union, the American Medical Association, U.S. regulatory agencies, and other organizations have found GMO foods to be safe, but skeptics contend that it is still too early to judge the long-term health and ecological effects of such crops. In the late 20th and early 21st centuries, the land area planted in genetically modified crops increased dramatically, from 1.7 million hectares (4.2 million acres) in 1996 to 160 million hectares (395 million acres) by 2011.

Overall, the revenues of U.S. and European biotechnology industries roughly doubled over the five-year period from 1996 through 2000. Rapid growth continued into the 21st century, fueled by the introduction of new products, particularly in health care.

See original here:
biotechnology | Definition, Examples, & Applications ...

Read More...

Plant genetics – Wikipedia

June 26th, 2018 8:45 am

Plant genetics is the study of genes, genetic variation, and heredity specifically in Plants.[1][2] It is generally considered a field of biology and botany, but intersects frequently with many other life sciences and is strongly linked with the study of information systems. Plant genetics is similar in many ways to animal genetics but differs in a few key areas.

The discoverer of genetics is Gregor Mendel, a late 19th-century scientist and Augustinian friar. Mendel studied "trait inheritance", patterns in the way traits are handed down from parents to offspring. He observed that organisms (pea plants) inherit traits by way of discrete "units of inheritance". This term, still used today, is a somewhat ambiguous definition of what is referred to as a gene. Much of Mendel's work with plants still forms the basis for modern plant genetics.

Plants, like all known organisms, use DNA to pass on their traits. Animal genetics often focuses on parentage and lineage, but this can sometimes be difficult in plant genetics due to the fact that plants can, unlike most animals, can self-fertilize. Speciation can be easier in many plants due to unique genetic abilities, such as being well adapted to polyploidy. Plants are unique in that they are able to make their own food via photosynthesis, a process which is achieved by use of a structure mostly exclusive to plants: chloroplasts. Chloroplasts, like the superficially similar mitochondria, possess their own DNA. Chloroplasts thus provide an additional reservoir for genes and genetic diversity, and an extra layer of genetic complexity not found in animals.

The study of plant genetics has major economic impacts: many staple crops are genetically modified to increase yields, confer pest and disease resistance, provide resistance to herbicides, or to increase their nutritional value.

The field of plant genetics began with the work of Gregor Mendel, who is often called the "father of genetics". He was an Augustinian priest and scientist born on 20 July 1822 in Austria-Hungary. He worked at the Abbey of St. Thomas in Brno , where his organism of choice for studying inheritance and traits was the pea plant. Mendel's work tracked many phenotypic traits of pea plants, such as their height, flower color, and seed characteristics. Mendel showed that the inheritance of these traits follows particular laws, which were later named after him. His seminal work on genetics was published in 1866, but went almost entirely unnoticed until 1900. Mendel died in 1884. The significance of Mendel's work was not recognized until the turn of the 20th century. Its rediscovery prompted the foundation of modern genetics.

Deoxyribonucleic acid (DNA) is a nucleic acid that contains the genetic instructions used in the development and functioning of all known living organisms and some viruses. The main role of DNA molecules is the long-term storage of information. DNA is often compared to a set of blueprints or a recipe, or a code, since it contains the instructions needed to construct other components of cells, such as proteins and RNA molecules. The DNA segments that carry this genetic information are called genes, but other DNA sequences have structural purposes, or are involved in regulating the use of this genetic information. Geneticists, including plant geneticists, use this sequencing of DNA to their advantage as they splice and delete certain genes and regions of the DNA molecule to produce a different or desired genotype and thus, also producing a different phenotype.

Plants, like all other known living organisms, pass on their traits using DNA. Plants however are unique from other living organisms in the fact that they have Chloroplasts. Like mitochondria, chloroplasts have their own DNA. Like animals, plants experience somatic mutations regularly, but these mutations can contribute to the germ line with ease, since flowers develop at the ends of branches composed of somatic cells. People have known of this for centuries, and mutant branches are called "sports". If the fruit on the sport is economically desirable, a new cultivar may be obtained.

Some plant species are capable of self-fertilization, and some are nearly exclusively self-fertilizers. This means that a plant can be both mother and father to its offspring, a rare occurrence in animals. Scientists and hobbyists attempting to make crosses between different plants must take special measures to prevent the plants from self-fertilizing. In plant breeding, people create hybrids between plant species for economic and aesthetic reasons. For example, the yield of Corn has increased nearly five-fold in the past century due in part to the discovery and proliferation of hybrid corn varieties.[3] Plant genetics can be used to predict which combination of plants may produce a plant with Hybrid vigor, or conversely many discoveries in Plant genetics have come from studying the effects of hybridization.

Plants are generally more capable of surviving, and indeed flourishing, as polyploids. Polyploid organisms have more than two sets of homologous chromosomes. For example, humans have two sets of homologous chromosomes, meaning that a typical human will have 2 copies each of 23 different chromosomes, for a total of 46. Wheat on the other hand, while having only 7 distinct chromosomes, is considered a hexaploid and has 6 copies of each chromosome, for a total of 42.[4] In animals, inheritable germline polyploidy is less common, and spontaneous chromosome increases may not even survive past fertilization. In plants however this is no such problem, polyploid individuals are created frequently by a variety of processes, however once created usually cannot cross back to the parental type. Polyploid individuals, if capable of self-fertilizing, can give rise to a new genetically distinct lineage, which can be the start of a new species. This is often called "instant speciation". Polyploids generally have larger fruit, an economically desirable trait, and many human food crops, including wheat, maize, potatoes, peanuts,[5] strawberries and tobacco, are either accidentally or deliberately created polyploids.

Arabidopsis thaliana, also known as thale cress, has been the model organism for the study of plant genetics. As Drosphila, a species of fruit fly, was to the understanding of early genetics, so has been arabidopsis to the understanding of plant genetics.

Genetically modified (GM) foods are produced from organisms that have had changes introduced into their DNA using the methods of genetic engineering. Genetic engineering techniques allow for the introduction of new traits as well as greater control over traits than previous methods such as selective breeding and mutation breeding.[6]

Genetically modifying plants is an important economic activity: in 2017, 89% of corn, 94% of soybeans, and 91% of cotton produced in the US were from genetically modified strains[7]. Since the introduction of GM crops, yields have increased by 22%, and profits have increased to farmers, especially in the developing world, by 68%. An important side effect of GM crops has been decreased land requirements, [8]

Commercial sale of genetically modified foods began in 1994, when Calgene first marketed its unsuccessful Flavr Savr delayed-ripening tomato.[9][10] Most food modifications have primarily focused on cash crops in high demand by farmers such as soybean, corn, canola, and cotton. Genetically modified crops have been engineered for resistance to pathogens and herbicides and for better nutrient profiles.[11] Other such crops include the economically important GM papaya which are resistant to the highly destructive Papaya ringspot virus, and the nutritionally improved golden rice (it is however still in development).[12]

There is a scientific consensus[13][14][15][16] that currently available food derived from GM crops poses no greater risk to human health than conventional food,[17][18][19][20][21] but that each GM food needs to be tested on a case-by-case basis before introduction.[22][23] Nonetheless, members of the public are much less likely than scientists to perceive GM foods as safe.[24][25][26][27] The legal and regulatory status of GM foods varies by country, with some nations banning or restricting them, and others permitting them with widely differing degrees of regulation.[28][29][30][31] There are still ongoing public concerns related to food safety, regulation, labeling, environmental impact, research methods, and the fact that some GM seeds are subject to intellectual property rights owned by corporations.[32]

Genetic modification has been the cause for much research into modern plant genetics, and has also lead to the sequencing of many plant genomes. Today there are two predominant procedures of transforming genes in organisms: the "Gene gun" method and the Agrobacterium method.

The gene gun method is also referred to as "biolistics" (ballistics using biological components). This technique is used for in vivo (within a living organism) transformation and has been especially useful in monocot species like corn and rice.This approach literally shoots genes into plant cells and plant cell chloroplasts. DNA is coated onto small particles of gold or tungsten approximately two micrometres in diameter. The particles are placed in a vacuum chamber and the plant tissue to be engineered is placed below the chamber. The particles are propelled at high velocity using a short pulse of high pressure helium gas, and hit a fine mesh baffle placed above the tissue while the DNA coating continues into any target cell or tissue.

Transformation via Agrobacterium has been successfully practiced in dicots, i.e. broadleaf plants, such as soybeans and tomatoes, for many years. Recently it has been adapted and is now effective in monocots like grasses, including corn and rice. In general, the Agrobacterium method is considered preferable to the gene gun, because of a greater frequency of single-site insertions of the foreign DNA, which allows for easier monitoring. In this method, the tumor inducing (Ti) region is removed from the T-DNA (transfer DNA) and replaced with the desired gene and a marker, which is then inserted into the organism. This may involve direct inoculation of the tissue with a culture of transformed Agrobacterium, or inoculation following treatment with micro-projectile bombardment, which wounds the tissue.[33] Wounding of the target tissue causes the release of phenolic compounds by the plant, which induces invasion of the tissue by Agrobacterium. Because of this, microprojectile bombardment often increases the efficiency of infection with Agrobacterium. The marker is used to find the organism which has successfully taken up the desired gene. Tissues of the organism are then transferred to a medium containing an antibiotic or herbicide, depending on which marker was used. The Agrobacterium present is also killed by the antibiotic. Only tissues expressing the marker will survive and possess the gene of interest. Thus, subsequent steps in the process will only use these surviving plants. In order to obtain whole plants from these tissues, they are grown under controlled environmental conditions in tissue culture. This is a process of a series of media, each containing nutrients and hormones. Once the plants are grown and produce seed, the process of evaluating the progeny begins. This process entails selection of the seeds with the desired traits and then retesting and growing to make sure that the entire process has been completed successfully with the desired results.

Domingo, Jos L.; Bordonaba, Jordi Gin (2011). "A literature review on the safety assessment of genetically modified plants" (PDF). Environment International. 37: 734742. doi:10.1016/j.envint.2011.01.003. PMID21296423.

Krimsky, Sheldon (2015). "An Illusory Consensus behind GMO Health Assessment" (PDF). Science, Technology, & Human Values. 40: 132. doi:10.1177/0162243915598381.

And contrast:

Panchin, Alexander Y.; Tuzhikov, Alexander I. (January 14, 2016). "Published GMO studies find no evidence of harm when corrected for multiple comparisons". Critical Reviews in Biotechnology: 15. doi:10.3109/07388551.2015.1130684. PMID26767435.

and

Yang, Y.T.; Chen, B. (2016). "Governing GMOs in the USA: science, law and public health". Journal of the Science of Food and Agriculture. 96: 18511855. doi:10.1002/jsfa.7523. PMID26536836.

Pinholster, Ginger (October 25, 2012). "AAAS Board of Directors: Legally Mandating GM Food Labels Could "Mislead and Falsely Alarm Consumers"". American Association for the Advancement of Science. Retrieved February 8, 2016.

Go here to read the rest:
Plant genetics - Wikipedia

Read More...

Analysts Set $4.35 Price Target for Fulgent Genetics Inc …

June 26th, 2018 8:45 am

Fulgent Genetics Inc (NASDAQ:FLGT) has been assigned a consensus broker rating score of 3.00 (Hold) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One research analyst has rated the stock with a hold rating.

Brokers have set a 1 year consensus price objective of $4.35 for the company and are anticipating that the company will post ($0.05) EPS for the current quarter, according to Zacks. Zacks has also given Fulgent Genetics an industry rank of 70 out of 255 based on the ratings given to related companies.

Several equities analysts have recently weighed in on FLGT shares. Credit Suisse Group decreased their price target on shares of Fulgent Genetics from $6.50 to $6.00 and set an outperform rating on the stock in a research note on Thursday, March 1st. Piper Jaffray Companies downgraded shares of Fulgent Genetics from an overweight rating to a neutral rating in a research note on Thursday, March 1st. Finally, ValuEngine raised shares of Fulgent Genetics from a sell rating to a hold rating in a research note on Wednesday, May 2nd.

Shares of Fulgent Genetics traded down $0.27, hitting $4.19, during midday trading on Friday, MarketBeat.com reports. The companys stock had a trading volume of 11,472 shares, compared to its average volume of 12,262. The company has a market cap of $79.79 million, a P/E ratio of -38.09 and a beta of 0.28. Fulgent Genetics has a 12-month low of $2.72 and a 12-month high of $7.04.

Fulgent Genetics (NASDAQ:FLGT) last posted its quarterly earnings results on Monday, May 7th. The company reported ($0.06) earnings per share for the quarter, missing the Thomson Reuters consensus estimate of ($0.04) by ($0.02). The business had revenue of $4.65 million during the quarter. Fulgent Genetics had a negative return on equity of 7.62% and a negative net margin of 26.57%. analysts expect that Fulgent Genetics will post -0.29 earnings per share for the current year.

Fulgent Genetics Company Profile

Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, learning software, and genetic diagnostics tools and integrated laboratory processes.

Get a free copy of the Zacks research report on Fulgent Genetics (FLGT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Fulgent Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fulgent Genetics and related companies with MarketBeat.com's FREE daily email newsletter.

Continued here:
Analysts Set $4.35 Price Target for Fulgent Genetics Inc ...

Read More...

Myriad Genetics (MYGN) versus Quotient (QTNT) Head-To-Head …

June 26th, 2018 8:45 am

Myriad Genetics (NASDAQ: MYGN) and Quotient (NASDAQ:QTNT) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, earnings, institutional ownership, risk and valuation.

Risk & Volatility

Myriad Genetics has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, Quotient has a beta of 0.25, meaning that its stock price is 75% less volatile than the S&P 500.

This table compares Myriad Genetics and Quotients net margins, return on equity and return on assets.

Insider & Institutional Ownership

61.5% of Quotient shares are owned by institutional investors. 6.7% of Myriad Genetics shares are owned by company insiders. Comparatively, 29.0% of Quotient shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings and price targets for Myriad Genetics and Quotient, as reported by MarketBeat.

Myriad Genetics currently has a consensus price target of $30.91, suggesting a potential downside of 20.48%. Quotient has a consensus price target of $11.50, suggesting a potential upside of 30.68%. Given Quotients stronger consensus rating and higher probable upside, analysts plainly believe Quotient is more favorable than Myriad Genetics.

Earnings and Valuation

This table compares Myriad Genetics and Quotients gross revenue, earnings per share and valuation.

Myriad Genetics has higher revenue and earnings than Quotient. Quotient is trading at a lower price-to-earnings ratio than Myriad Genetics, indicating that it is currently the more affordable of the two stocks.

Summary

Myriad Genetics beats Quotient on 8 of the 13 factors compared between the two stocks.

About Myriad Genetics

Myriad Genetics, Inc., a molecular diagnostic company, focuses on developing and marketing novel predictive medicine, personalized medicine, and prognostic medicine tests worldwide. The company offers molecular diagnostic tests, including myRisk Hereditary Cancer, a DNA sequencing test for hereditary cancers; BRACAnalysis, a DNA sequencing test to assess the risk of developing breast and ovarian cancer; BART, a DNA sequencing test for hereditary breast and ovarian cancer; BRACAnalysis CDx, a DNA sequencing test for use as a companion diagnostic with the platinum based chemotherapy agents and poly ADP ribose inhibitor Lynparza; and Tumor BRACAnalysis CDx, a DNA sequencing test that is designed to be utilized to predict response to DNA damaging agents. It also provides COLARIS, a DNA sequencing test for colorectal and uterine cancer; COLARIS AP, a DNA sequencing test for colorectal cancer; Vectra DA, a protein quantification test for assessing the disease activity of rheumatoid arthritis; Prolaris, a RNA expression test for assessing the aggressiveness of prostate cancer; and EndoPredict, a RNA expression test for assessing the aggressiveness of breast cancer. In addition, the company offers myPath Melanoma, a RNA expression test for diagnosing melanoma; myChoice HRD, a companion diagnostic to measure three modes of homologous recombination deficiency; and GeneSight, a DNA genotyping test to optimize psychotropic drug selection for neuroscience patients. Further, it provides biomarker discovery, and pharmaceutical and clinical services to the pharmaceutical, biotechnology, and medical research industries; and operates an internal medicine emergency hospital primarily for internal medicine and hemodialysis. The company has collaboration with AstraZeneca for the development of an indication for BRACAnalysis CDx. Myriad Genetics, Inc. was founded in 1991 and is headquartered in Salt Lake City, Utah.

About Quotient

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening. It also develops, manufactures, and commercializes conventional reagent products for blood grouping, including antisera products that are used to identify blood-group antigens; reagent red blood cells, which enable the identification of blood-group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company sells its products to donor collection agencies and testing laboratories, hospitals, independent patient testing laboratories, reference laboratories, blood banking operations, and other diagnostic companies, as well as to original equipment manufacturers. Quotient Limited was founded in 2007 and is based in Penicuik, the United Kingdom.

Receive News & Ratings for Myriad Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myriad Genetics and related companies with MarketBeat.com's FREE daily email newsletter.

See the original post:
Myriad Genetics (MYGN) versus Quotient (QTNT) Head-To-Head ...

Read More...

Arthritis – Diagnosis and treatment – Mayo Clinic

June 26th, 2018 8:44 am

Diagnosis

During the physical exam, your doctor will check your joints for swelling, redness and warmth. He or she will also want to see how well you can move your joints. Depending on the type of arthritis suspected, your doctor may suggest some of the following tests.

The analysis of different types of body fluids can help pinpoint the type of arthritis you may have. Fluids commonly analyzed include blood, urine and joint fluid. To obtain a sample of your joint fluid, your doctor will cleanse and numb the area before inserting a needle in your joint space to withdraw some fluid (aspiration).

These types of tests can detect problems within your joint that may be causing your symptoms. Examples include:

Arthritis treatment focuses on relieving symptoms and improving joint function. You may need to try several different treatments, or combinations of treatments, before you determine what works best for you.

The medications used to treat arthritis vary depending on the type of arthritis. Commonly used arthritis medications include:

Physical therapy can be helpful for some types of arthritis. Exercises can improve range of motion and strengthen the muscles surrounding joints. In some cases, splints or braces may be warranted.

If conservative measures don't help, your doctor may suggest surgery, such as:

Explore Mayo Clinic studies testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this disease.

In many cases, arthritis symptoms can be reduced with the following measures:

Many people use alternative remedies for arthritis, but there is little reliable evidence to support the use of many of these products. The most promising alternative remedies for arthritis include:

While you might first discuss your symptoms with your family doctor, he or she may refer you to a doctor who specializes in the treatment of joint problems (rheumatologist) for further evaluation.

Before your appointment, make a list that includes:

Your doctor may ask some of the following questions:

Read more from the original source:
Arthritis - Diagnosis and treatment - Mayo Clinic

Read More...

The 5 Worst Foods To For Arthritis – Natural Health Reports

June 26th, 2018 8:44 am

This video player is not support on your device, please click HERE to try a different player. We apologize for this inconvenience.

How long would YOU like to be pain free?

Look, I know you're skeptical. You should be. Look at all the big drug companies who are lying to you each and every day trying to convince you that their dangerous (sometimes deadly!) drugs are safe.

So I thought there's no better way for you to find out if Heal-n-Soothe will work for you, than having you try it. And that's why I'd like to send you a 90 count bottle, a 30 day supply, for free. You just pay the shipping and handling.

No matter what your arthritis pain level and frequency, fill out the risk-free acceptance form below to see how well Heal-n-Soothe Arthritis will work for you.

STEP 1: Where Should We Ship Your FREE Bottle?

Country *

Choose your country AFGHANISTANALBANIAALGERIAAMERICAN SAMOAANDORRAANGOLAANGUILLAANTARCTICAANTIGUA AND BARBUDAARGENTINAARMENIAARUBAAUSTRALIAAUSTRIAAZERBAIJANBAHAMASBAHRAINBANGLADESHBARBADOSBELARUSBELGIUMBELIZEBENINBERMUDABHUTANBOLIVIABOSNIA AND HERZEGOVINABOTSWANABOUVET ISLANDBRAZILBRITISH INDIAN OCEAN TERRITORYBRUNEI DARUSSALAMBULGARIABURKINA FASOBURUNDICAMBODIACAMEROONCANADACAPE VERDECAYMAN ISLANDSCENTRAL AFRICAN REPUBLICCHADCHILECHINACHRISTMAS ISLANDCOCOS (KEELING) ISLANDSCOLOMBIACOMOROSCONGOCONGO, THE DEMOCRATIC REPUBLIC OF THECOOK ISLANDSCOSTA RICACOTE D'IVOIRECROATIACUBACYPRUSCZECH REPUBLICDENMARKDJIBOUTIDOMINICADOMINICAN REPUBLICECUADOREGYPTEL SALVADOREQUATORIAL GUINEAERITREAESTONIAETHIOPIAFALKLAND ISLANDS (MALVINAS)FAROE ISLANDSFIJIFINLANDFRANCEFRENCH GUIANAFRENCH POLYNESIAFRENCH SOUTHERN TERRITORIESGABONGAMBIAGEORGIAGERMANYGHANAGIBRALTARGREECEGREENLANDGRENADAGUADELOUPEGUAMGUATEMALAGUINEAGUINEA-BISSAUGUYANAHAITIHEARD ISLAND AND MCDONALD ISLANDSHOLY SEE (VATICAN CITY STATE)HONDURASHONG KONGHUNGARYICELANDINDIAINDONESIAIRAN, ISLAMIC REPUBLIC OFIRAQIRELANDISRAELITALYJAMAICAJAPANJORDANKAZAKHSTANKENYAKIRIBATIKOREA, DEMOCRATIC PEOPLE'S REPUBLIC OFKOREA, REPUBLIC OFKUWAITKYRGYZSTANLAO PEOPLE'S DEMOCRATIC REPUBLICLATVIALEBANONLESOTHOLIBERIALIBYAN ARAB JAMAHIRIYALIECHTENSTEINLITHUANIALUXEMBOURGMACAOMACEDONIA, THE FORMER YUGOSLAV REPUBLIC OFMADAGASCARMALAWIMALAYSIAMALDIVESMALIMALTAMARSHALL ISLANDSMARTINIQUEMAURITANIAMAURITIUSMAYOTTEMEXICOMICRONESIA, FEDERATED STATES OFMOLDOVA, REPUBLIC OFMONACOMONGOLIAMONTSERRATMOROCCOMOZAMBIQUEMYANMARNAMIBIANAURUNEPALNETHERLANDSNETHERLANDS ANTILLESNEW CALEDONIANEW ZEALANDNICARAGUANIGERNIGERIANIUENORFOLK ISLANDNORTHERN MARIANA ISLANDSNORWAYOMANPAKISTANPALAUPALESTINIAN TERRITORY, OCCUPIEDPANAMAPAPUA NEW GUINEAPARAGUAYPERUPHILIPPINESPITCAIRNPOLANDPORTUGALPUERTO RICOQATARREUNIONROMANIARUSSIAN FEDERATIONRWANDASAINT HELENASAINT KITTS AND NEVISSAINT LUCIASAINT PIERRE AND MIQUELONSAINT VINCENT AND THE GRENADINESSAMOASAN MARINOSAO TOME AND PRINCIPESAUDI ARABIASENEGALSERBIA AND MONTENEGROSEYCHELLESSIERRA LEONESINGAPORESLOVAKIASLOVENIASOLOMON ISLANDSSOMALIASOUTH AFRICASOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDSSPAINSRI LANKASUDANSURINAMESVALBARD AND JAN MAYENSWAZILANDSWEDENSWITZERLANDSYRIAN ARAB REPUBLICTAIWAN, PROVINCE OF CHINATAJIKISTANTANZANIA, UNITED REPUBLIC OFTHAILANDTIMOR-LESTETOGOTOKELAUTONGATRINIDAD AND TOBAGOTUNISIATURKEYTURKMENISTANTURKS AND CAICOS ISLANDSTUVALUUGANDAUKRAINEUNITED ARAB EMIRATESUNITED KINGDOMUNITED STATESUNITED STATES MINOR OUTLYING ISLANDSURUGUAYUZBEKISTANVANUATUVENEZUELAVIET NAMVIRGIN ISLANDS, BRITISHVIRGIN ISLANDS, U.S.WALLIS AND FUTUNAWESTERN SAHARAYEMENZAMBIAZIMBABWE

State *

Choose your state AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUSAF, AmericasUSAF, EuropeUSAF, PacificUtahVermontVirginiaWashingtonWashington DCWest VirginiaWisconsinWyoming

Get Your FREE Bottle

Learn about the trouble making vegetable, YES VEGETABLE... that can make your Arthritis worse. (And Make you feel 5 - 10 years older.)

The secret switch inside your body that you can flip to help make it start acting like it did when you were 25 years old.

The real reason why pain killers don't help your pain.

Which special superfood can actually counteract the damage or arthritis.

Adler A, Holub B. Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. American Journal of Clinical Nutrition. 1997 Feb;65(2):445-50.

NIAMS, NIH, Bethesda, Maryland 20892, USA. Arthritis & Rheumatology (Impact Factor: 7.87).06/1998; 41(5):778-99. DOI: 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V Source: PubMed

Hrlimann, David, Frank Enseleit, and Priv-Doz Dr Frank Ruschitzka. Rheumatoide arthritis, inflammation und atherosklerose. Herz 29.8 (2004): 760-768.

Schett, Georg. Rheumatoid arthritis: inflammation and bone loss. Wiener Medizinische Wochenschrift 156.1-2 (2006): 34-41.

More here:
The 5 Worst Foods To For Arthritis - Natural Health Reports

Read More...

About Us American Board of Preventive Medicine

June 26th, 2018 8:44 am

What is Preventive Medicine?

Preventive Medicine is the specialty of medical practice that focuses on the health of individuals, communities, and defined populations. Its goal is to protect, promote, and maintain health and well-being and to prevent disease, disability, and death, Preventive medicine specialists have core competencies in biostatistics, epidemiology, environmental and occupational medicine, planning and evaluation of health services, management of healthcare organizations, research into causes of disease and injury in population groups, and the practice of prevention in clinical medicine. They apply knowledge and skills gained from the medical, social, economic, and behavioral sciences.

Preventive medicine has three specialty areas with common core knowledge, skills, and competencies that emphasize different populations, environments, or practice settings:

Preventive medicine also encompasses 4 subspecialty areas, including:

The purpose of the American Board of Preventive Medicine is:

View board members

The American Board of Preventive Medicine, Inc. (ABPM) is a member board of the American Board of Medical Specialties. ABPM originated from recommendations of a joint committee comprised of representatives from the Section of Preventive and Industrial Medicine and Public Health of the American Medical Association and the Committee on Professional Education of the American Public Health Association. The Board was incorporated under the laws of the State of Delaware on June 29, 1948 as The American Board of Preventive Medicine and Public Health, Incorporated.

In 1952 the name was changed to The American Board of Preventive Medicine, Inc. In February 1953, the Advisory Board of Medical Specialties and the Council on Medical Education and Hospitals of the American Medical Association authorized certification by the Board of preventive medicine specialists in Aviation Medicine (the name was changed to Aerospace Medicine in 1963); in June 1955, preventive medicine specialists in Occupational Medicine; in November 1960, preventive medicine specialists in General Preventive Medicine; and in 1983, Public Health and General Preventive Medicine were combined into one specialty area of certification. In 1989 the American Board of Preventive Medicine was approved to offer a subspecialty certificate in Undersea Medicine (the name was changed to Undersea and Hyperbaric Medicine in 1999), in 1992 a subspecialty certificate in Medical Toxicology, in 2010 a subspecialty certificate in Clinical Informatics, and in 2017 a subspecialty in Addiction Medicine.

The Board is a non-profit corporation, and no member (officer or director) may receive any salary or compensation for services. The Board consists of members nominated by the organizations listed below:

More here:
About Us American Board of Preventive Medicine

Read More...

Integrative Medicine Clinic of Arizona | Integrative …

June 26th, 2018 8:44 am

Rising healthcare costs and decreased reimbursement payments have created an environment where most primary care physicians are forced to see 30 to 50 patients per day. This makes it virtually impossible to establish strong relationships and serve the needs of patients. You have most likely felt the end effects of these changes with rushed medical appointments, lack of focus on your concerns and overuse of pharmaceuticals to treat the symptoms, but not actually fix the cause of your condition.

We have a better solution.

The Integrative Medicine Clinic of Arizona is committed to focusing on you and thoroughly addressing your health.

Our physician, Cheri Dersam, M.D., is trained in both Traditional and Integrative Medicine. This allows her to fully address your health concerns today and reduce your risks for health problems in the future.

She takes the time to listen to your concerns and turn the focus back to you. By fully exploring your past and present health, nutrition, activity and lifestyle and utilizing conventional and innovative lab testing, she will explore the root cause of your health concerns. She will also investigate genetic risk factors that can predict the likelihood you may develop conditions such as cardiovascular disease, stroke, Alzheimers Disease and certain cancers. Dr. Dersam will then recommend a health promotion plan personalized to you. This will include balancing your nutrition, digestion, activity, stress, sleep, hormones, and adjusting medications as needed.

Because we do not participate with any insurance company contracts, this frees us from all of the time-consuming administrative hassles and we can spend more time with you. This translates into more time with the physician and allows us to offer you a team approach to your healthcare. This team includes a physician, nutritionist, health coach and acupuncturist with the addition of a chiropractor, psychologist and/or other alternative therapists as needed at discounted prices.

Choose a primary care physician who has time to listen to your concerns, is highly trained and offers an effective treatment plan that is personalized to you.

If you are ready to take charge of your health, join our membership practice today or book a free 20-minute consultation appointment by calling us at (480)766-3586.

See the original post here:
Integrative Medicine Clinic of Arizona | Integrative ...

Read More...

Where Do We Get Adult Stem Cells? | Boston Children’s Hospital

June 26th, 2018 8:42 am

There are several ways adult stem cells can be isolated, most of which are being actively explored by our researchers.

1) From the body itself:Scientists are discovering that many tissues and organs contain a small number of adult stem cells that help maintain them. Adult stem cells have been found in the brain, bone marrow, blood vessels, skeletal muscle, skin, teeth, heart, gut, liver, and other (although not all) organs and tissues. They are thought to live in a specific area of each tissue, where they may remain dormant for years, dividing and creating new cells only when they are activated by tissue injury, disease or anything else that makes the body need more cells.

Adult stem cells can be isolated from the body in different ways, depending on the tissue. Blood stem cells, for example, can be taken from a donors bone marrow, from blood in the umbilical cord when a baby is born, or from a persons circulating blood. Mesenchymal stem cells, which can make bone, cartilage, fat, fibrous connective tissue, and cells that support the formation of blood can also be isolated from bone marrow. Neural stem cells (which form the brains three major cell types) have been isolated from the brain and spinal cord. Research teams at Childrens, headed by leading scientists Stuart Orkin, MD and William Pu, MD, both affiliate members of the Stem Cell Program, recently isolated cardiac stem cells from the heart.

Isolating adult stem cells, however, is just the first step. The cells then need to be grown to large enough numbers to be useful for treatment purposes. The laboratory of Leonard Zon, MD, director of the Stem Cell Program, has developed a technique for boosting numbers of blood stem cells thats now in Phase I clinical testing.

2) From amniotic fluid:Amniotic fluid, which bathes the fetus in the womb, contains fetal cells including mesenchymal stem cells, which are able to make a variety of tissues. Many pregnant women elect to have amniotic fluid drawn to test for chromosome defects, the procedure known as amniocentesis. This fluid is normally discarded after testing, but Childrens Hospital Boston surgeon Dario Fauza, MD, a Principal Investigator at Childrens and an affiliate member of the Stem Cell Program, has been investigating the idea of isolating mesenchymal stem cells and using them to grow new tissues for babies who have birth defects detected while they are still in the womb, such as congenital diaphragmatic hernia. These tissues would match the baby genetically, so would not be rejected by the immune system, and could be implanted either in utero or after the baby is born.

3) From pluripotent stem cells:Because embryonic stem cells and induced pluripotent cells (iPS cells), which are functionally similar, are able to create all types of cells and tissues, scientists at Childrens and elsewhere hope to use them to produce many different kinds of adult stem cells. Laboratories around the world are testing different chemical and mechanical factors that might prod embryonic stem cells or iPS cells into forming a particular kind of adult stem cell. Adult stem cells made in this fashion would potentially match the patient genetically, eliminating both the problem of tissue rejection and the need for toxic therapies to suppress the immune system.

4) From other adult stem cells:A number of research groups have reported that certain kinds of adult stem cells can transform, or differentiate, into apparently unrelated cell types (such as brain stem cells that differentiate into blood cells or blood-forming cells that differentiate into cardiac muscle cells). This phenomenon, called transdifferentiation, has been reported in some animals. However, its still far from clear how versatile adult stem cells really are, whether transdifferentiation can occur in human cells, or whether it could be made to happen reliably in the lab.

More here:
Where Do We Get Adult Stem Cells? | Boston Children's Hospital

Read More...

Journal of Fertilization: In Vitro – IVF-Worldwide …

June 25th, 2018 9:48 am

IVF Treatment

Unlike artificial insemination wherein the sperm is introduced into uterus, in IVF, the sperm and egg are fertilized outside the uterus in laboratory conditions. The fertilized egg is then introduced into womans uterus. Most often, IVF is not the first treatment suggested for infertility because of its complex nature and costs involved in it.

Related Journals of IVF Treatment

Gynecology & Obstetrics; Andrology & Gynecology: Current Research; Andrology-Open Access; Reproductive Biomedicine Online; Human Reproduction; Fertility and Sterility; Molecular Human Reproduction, Journal of Assisted Reproduction and Genetics; Acta Obstetricia Et Gynecologica Scandinavica; European Journal of Obstetrics & Gynecology and Reproductive Biology

Recent advances and latest techniques in IVF treatment are enabling to achieve high success rates and minimizing the chances of multiple pregnancies and birth defects. The refinements are being done in every step of IVF i.e., ovarian stimulation, collection of sperm, fertilization, embryo development in lab conditions and introduction of embryo into uterus.

Related Journals of Advances in In-vitro Fertilization

International Journal of Andrology, Gynecology & Obstetrics; Andrology-Open Acce; Andrology & Gynecology: Current Research; Journal of Assisted Reproduction and Genetics; Fertility and Sterility; American Journal of Obstetrics and Gynecology; Reproductive Biology and Endocrinology; Archives of Gynecology and Obstetrics; Reproductive Medicine and Biology

Infertility is when not being able to achieve pregnancy even after regular intercourse. It is the most common problem which suffers the couples from having children. Many treatments have been available with different success rates. They include fertility drugs, intrauterine insemination (IUI), in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), donor insemination (DI), egg (or embryo) donation and surrogacy.

Related Journals of Infertility Treatment

Gynecology & Obstetrics; Critical Care Obstetrics & Gynecology; Andrology & Gynecology: Current Research; Infertility and Reproductive Medicine Clinics of North America; Journal of Reproduction and Infertility; International Journal of Infertility and Fetal Medicine; Iranian Journal of Obstetrics, Gynecology and Infertility;Reproductive Biomedicine Online; Human Reproduction

Artificial Insemination (AI) is one of the infertility treatments available for both men and women. In this technique, the sperm is directly introduced into womans uterus, fallopian tube or cervix. The most common form of artificial insemination is intra Uterine Insemination (IUI). Although the success rate of this technique is less, it is the first infertility treatment doctor would suggest as it involves less cost and the treatment method is simple.

Related Journals of Artificial Insemination

Critical Care Obstetrics & Gynecology; Gynecology & Obstetrics; Andrology & Gynecology: Current Research; Theriogenology;Journal of Dairy Science; Animal Reproduction Science; Reproduction; Reproduction Fertility and Development; Reproduction in Domestic Animals

Reproductive genetics is a sub-filed of medical genetics that primarily involve conducting different tests for predicting possible outcomes of future pregnancies. The tests involve analyzing genetic material like chromosomes, genes, DNA, RNA and gene products for accessing genetic changes that have likelihood of causing some disease after pregnancy in either mother or child.

Related Journals of Reproductive Genetics

Human Reproduction and Genetic Ethics, Reproductive System & Sexual Disorders; Current Trends in Gynecologic Oncology; Andrology & Gynecology: Current Research; Journal of Assisted Reproduction and Genetics; Conservation Genetics; Animal Reproduction Science; Reproductive Biomedicine Online; Human Reproduction Update; PLoS Genetics

Semen analysis is the most common way of accessing infertility in men. It basically evaluates the quality and environment of sperm. The analysis involves testing various sperm parameters such as sperm morphology, sperm count, sperm motility etc. It helps to test sperm donors for quality sperm to be used in assisted reproductive techniques.

Related Journals of Semen Analysis and Sperm Characteristics

Andrology & Gynecology: Current Research; Andrology-Open Access; Reproductive System & Sexual Disorders; Fertility and Sterility; Asian Journal of Andrology; Theriogenology; Human Reproduction; Journal of Assisted Reproduction and Genetics; Reproductive Biomedicine Online

Endometriosis is disease condition in woman in which the tissue which normally grows inside the uterus will grow outside the uterus. The side effects of the condition are pelvic pain and infertility. In 70% of the cases, the pelvic pain would be severe during menstruation. The cause for such condition is not clearly understood yet.

Related Journals of Endometriosis Treatment

Gynecology & Obstetrics; Critical Care Obstetrics & Gynecology; Andrology & Gynecology: Current Research; Journal of Endometriosis; Journal of Minimally Invasive Gynecology; Human Reproduction; Fertility and Sterility; International Journal of Gynecology & Obstetrics; Obstetrical & Gynecological Survey

See the rest here:
Journal of Fertilization: In Vitro - IVF-Worldwide ...

Read More...

2018 Personalized Medicine Conference GRC

June 25th, 2018 9:44 am

Sunday2:00 pm - 8:00 pm

Arrival and Check-in

Dinner

Introductory Comments by GRC Site Staff / Welcome from the GRC Chair

Discussion Leader: Chih-Ming Ho (University of California, Los Angeles, USA)

Introduction by Discussion Leader

Dean Ho (BIGHEART, National University of Singapore, Singapore)

Discussion

Edward Kai-Hua Chow (Cancer Science Institute of Singapore, National University of Singapore, Singapore)

Discussion

Bin Tean Teh (National Cancer Centre Singapore, Singapore)

Discussion

General Discussion

Breakfast

Discussion Leader: Mien-Chie Hung (University of Texas MD Anderson Cancer Center, USA)

Introduction by Discussion Leader

Wei Zhang (Comprehensive Cancer Center, Wake Forest University, USA)

Discussion

Group Photo / Coffee Break

Chuan He (University of Chicago, USA)

Discussion

Jindan Yu (Northwestern University, USA)

Discussion

General Discussion

Lunch

Free Time

Poster Session

Dinner

Discussion Leader: Rita Yen-Hua Huang (Taipei Medical University, Taiwan)

Introduction by Discussion Leader

Ye-Guang Chen (Tsinghua University, China)

Discussion

Bradley Cairns (University of Utah, USA)

Discussion

General Discussion

Breakfast

Discussion Leader: Wei Jia (University of Hawaii Cancer Center, USA)

Introduction by Discussion Leader

Neal Rosen (Memorial Sloan Kettering Cancer Center, USA)

Discussion

Coffee Break

Van-Dang Chi (Ludwig Cancer Research, USA)

Discussion

Shengfang Jin (Agios Pharmaceuticals Inc, USA)

Discussion

General Discussion

Lunch

Poster Session

Discussion Leader: Tony S.K. Mok (Chinese University of Hong Kong, Hong Kong SAR China)

Introduction by Discussion Leader

Patrycja Nowak-Sliwinska (University of Geneva, Switzerland)

Discussion

Hong Wu (School of Life Sciences, Peking University, China)

Discussion

Jonathan Keats (Translational Genomics Research Institute (TGen) / City of Hope, USA)

Discussion

General Discussion

Dinner

Breakfast

Discussion Leader: Priscilla Kelly (Science, AAAS, USA)

Introduction by Discussion Leader

Pui-Yan Kwok (Institute of Biomedical Sciences, Academia Sinica, Taiwan)

Discussion

Sridhar Mani (Albert Einstein College of Medicine, USA)

Discussion

Coffee Break

Christiane Querfeld (Cutaneous Lymphoma Program, City of Hope, USA)

Discussion

Irene O.L. Ng (The University of Hong Kong, Hong Kong SAR China)

Discussion

General Discussion

Lunch

Free Time

Poster Session

Dinner

Business MeetingNominations for the Next Vice Chair; Fill in Conference Evaluation Forms; Discuss Future Site and Scheduling Preferences; Election of the Next Vice Chair

Discussion Leader: Richard Weinshilboum (Mayo Clinic, USA)

Introduction by Discussion Leader

James Lee (University of Pittsburgh School of Medicine, USA)

Discussion

Steven Offer (Mayo Clinic, USA)

Discussion

Liewei Wang (Mayo Clinic, USA)

Discussion

General Discussion

Breakfast

Discussion Leader: Chien-Tsun Kuan (Development Center for Biotechnology, Taiwan)

Introduction by Discussion Leader

Arjan Griffioen (VU University Medical Center, The Netherlands)

Discussion

John Williams (Beckman Research Institute, City of Hope, USA)

Discussion

Coffee Break

Xianting Ding (Institute for Personalized Medicine, Shanghai Jiao Tong University, China)

Discussion

Ali Zarrinpar (Division of Transplantation and Hepatobiliary Surgery, University of Florida College of Medicine, USA)

Discussion

General Discussion

Lunch

Free Time

Read more here:
2018 Personalized Medicine Conference GRC

Read More...

About the Fred A. Litwin Family Centre in Genetic Medicine

June 24th, 2018 7:45 am

');$.get(url, function(data){$('.rightNav-wp-' + idx).html(data);});}var rightPanel = $('#rightpanel');if (rightPanel.length == 0) rightPanel = $('#rightpanel-placeholder');$.each(webparts, function(i,e){addWp(i,e);});}if (!window.location.origin) {window.location.origin = window.location.protocol + '//' + window.location.host;}var pn = _spPageContextInfo.serverRequestPath.replace(/^//ig,''),pNames = [], curSite,webparts = UHNPageData.siteWebParts ? UHNPageData.siteWebParts.rows : []; // from XSLTDataViewWebpartwhile (pn.indexOf('/') > 0) {pNames.push(pn);pn = pn.substr(0, pn.lastIndexOf('/'));}pNames.push(pn);for (var i = 0; i 0) {continue;}curSite = webparts[j];j = webparts.length;i = pNames.length;}}}if (curSite === undefined) {curSite = webparts.filter(function(e){return e.Title == 'Global';})[0];if (curSite === undefined) return reloadSiteWebParts();}if (!curSite.HideRightNav) {generateHTML(curSite.Webparts);$('#rightpanel').show();} else {HideRightNav = curSite.HideRightNav;$('#rightpanel').hide();}$('#MSO_ContentTable').toggleClass('col-sm-9', !curSite.HideRightNav);}window.HideRightNav = false;window.safetyAttempts = 0;initRightNav();$(function(){var userGroup = [2164];if (_spPageContextInfo.userId) {$().SPServices({operation: 'GetUserCollectionFromGroup',groupName: 'Designers',completefunc: function (xDataUser, Status) {$(xDataUser.responseXML).find("User").each(function() {userGroup.push(parseInt($(this).attr("ID").trim()));});if ($.inArray(_spPageContextInfo.userId, userGroup) > -1) {$('#title-links ul').prepend('

Read the original post:
About the Fred A. Litwin Family Centre in Genetic Medicine

Read More...

Biotechnology Career | Jobs, Salary, Courses & Colleges in …

June 24th, 2018 7:43 am

Biotechnology is one of the most progressive and beneficial scientific advances of the last quarter century. An interdisciplinary field that includes mathematics, physics, chemistry, engineering and others, it combines various- technologies to either create a new product or modify an existing one to suit our needs.

Its widespread application across multiple industries like food, pharmaceutical, chemical, bio-products, textiles, medicine, nutrition, environmental conservation and animal sciences makes a career in biotechnology one of the fastest growing fields with ample opportunities for qualified professionals.

Biotechnology combines the theoretical (genetics, molecular biology, biochemistry, embryology and cell biology), and the practical (chemical engineering, information technology and robotics)scientific aptitude, a keen interest in the biological sciences, problem solving skills. An analytical mind is essential for successful career in biotechnology.

The candidate should be methodical and patient by nature, able to work neatly and accurately and have a flair for laboratory work. The ability to work independently is another important aspect. The knowledge of computers is a must.

10 + 2 science stream graduates can opt for a B.Tech (Biotechnology) or an integrated M. Tech (Biotechnology); science stream graduates from any field (engineering, medicine etc.) can opt for a M. Tech (Biotechnology).

IIT Delhi and Kharagpur offer admission into a five year integrated M.Tech through a Joint Entrance Examination.

The Jawaharlal Nehru University, New Delhi conducts an all-India entrance examination for their Msc Biotechnology program.

Any candidate with an undergraduate degree from a 10+2+3 system with at least 55% marks in:

Is eligible to apply for the JNU Msc(Biotechnology) as well as others.

The Department of Biotechnology (DBT) also offers postgraduate courses in selected institutions, and through four prominent research institutes, further provides a two-year support for post doctoral programs; the objective is to prepare long term biotech professionals and scientists for frontier research and advance research methodologies.

Two other institutes, backed by the DBT, provide a one-year MD/MS training in medical biotech. The cover fields such as:

SRM University offers B.Tech in Biotechnology, Genetic Engineering, and Bioinformatics. They also offer an M.Tech in Biotechnology and Biomedical Engineering.

Applications Forms Now Available

Affordable and intelligent R&D partnering with Chinese and American corporate bodies has great scope in mining Indias biotech potential and co-developing tech; India has a global market worth a $91 billion. Thats why so many global pharma companies are flocking to India for their own R&D initiatives.

A bio-technologist may find jobs in various quarters. Biotechnology jobs in India can be found in the following fields:

While government institutes and organizations, such as Department of Biotechnology (DBT), several agriculture, dairy and horticulture institutes may offer job opportunities to Biotechnology professionals, one can expect the best salary in private sector.

Drug companies in biotechnology like Dabur, Ranbaxy, Hindustan Lever and Dr Reddy's Labs that have their R & D units offer Biotechnology professionals with handsome pay-packages. There are also ample opportunities available to bio-technologists in the food processing industry, chemical industry and the textile industry.

Some industries employ bio-technologists in their marketing divisions to develop business in sectors where their products would be required.

The major companies, hiring bio-technologists, include Hindustan Lever, Thapar Group, Indo American Hybrid Seeds, Bincon India Ltd., IDPL and Hindustan Antibiotics.

The Government of India provides large-scale employment to most bio-technologists in its research laboratories. Those employed as researchers in government sector can have a starting salary of Rs. 9000 per month along with government perks/allowances.

Private sector pharmaceutical companies generally offer salary between Rs. 12,000- Rs. 20,000 per month to an entry-level postgraduate. A skilled and experienced bio-technologist can get salaries far beyond his expectations.

Indian Institute Of Technology

Indian Institute Of Technology

Vellore Institute Of Technology

Indian Institute Of Technology, Guwahati

National Institute Of Technology, Warangal

PSG College Of Technology

National Institute Of Technology, Durgapur

Manipal Institute Of Technology

BMS College of Engineering

Chaitanya Bharathi Institute of Technology

PES Institute of Technology

SASTRA University

National Institute of Technology, Raipur

GITAM University

Karunya University

Note: Selection through All India Combined Entrance Test

Courses Offered : B.Tech in Biotechnology, Genetic Engineering, and Bioinformatics. M.Tech in Biotechnology and Biomedical Engineering

Visit link:
Biotechnology Career | Jobs, Salary, Courses & Colleges in ...

Read More...

Centenarian – Wikipedia

June 24th, 2018 7:42 am

A centenarian is a person who lives to or beyond the age of 100 years. Because life expectancies worldwide are far below 100, and it is extremely rare to live to see one's 100th birthday, the term is invariably associated with extreme longevity. In 2012, the United Nations estimated that there were 316,600 living centenarians worldwide.[1]

As life expectancy is increasing across the world, and the world population has also increased rapidly, the number of centenarians is expected to increase quickly in the future.[2] According to the UK ONS, one-third of babies born in 2013 in the UK are expected to live to 100.[3]

A supercentenarian, sometimes hyphenated as super-centenarian, is a human (or individual species) who has lived to the age of 110 or more, something only achieved by about one in 1,000 centenarians.

Even rarer is a person who has lived to age 115 there are only 46 people in recorded history who have indisputably reached this age, of whom only Chiyo Miyako, Giuseppina Projetto, Kane Tanaka, Maria Giuseppa Robucci and Shimoe Akiyama are living as of 2018.[4][5][6]

There has only been one known case of a person of 120 years of age or older whose birth was independently verified by historical documents: Jeanne Calment, who lived to the age of 122 years, 164 days.

Japan currently has the greatest number of known centenarians of any nation with 67,824 according to their 2017 census, along with the highest proportion of centenarians at 34.85 per 100,000 people. Japan started recording its centenarians in 1963. The number of Japanese centenarians in that year was 153, but surpassed the 10,000 mark in 1998; 20,000 in 2003; and 40,000 in 2009.

According to a 1998 United Nations demographic survey, Japan is expected to have 272,000 centenarians by 2050;[7] other sources suggest that the number could be closer to 1 million.[8] The incidence of centenarians in Japan was one per 3,522 people in 2008.[9]

In Japan, the number of centenarians is highly skewed towards females. Japan in fiscal year 2016 had 57,525 female centenarians, while males were 8,167, a ratio of 7:1. The increase of centenarians was even more skewed at 11.6:1.[10]

The total number of living centenarians in the world remains uncertain. It was estimated by the Population Division of the United Nations as 23,000 in 1950, 110,000 in 1990, 150,000 in 1995, 209,000 in 2000, 324,000 in 2005[11] and 455,000 in 2009.[12] However, these older estimates did not take into account the contemporary downward adjustments of national estimates made by several countries such as the United States; thus, in 2012, the UN estimated there to be only 316,600 centenarians worldwide.[1] The following table gives estimated centenarian populations by country, including both the latest and the earliest known estimates, where available.

In many countries, people receive a gift or congratulations from state institutions on their 100th birthday.

Swedish centenarians receive a telegram from the King and Queen of Sweden.[62]

Centenarians born in Italy receive a letter from the President of Italy.

In the United Kingdom and the other Commonwealth realms, the British (and Commonwealth) monarch sends greetings (formerly as a telegram) on the 100th birthday and on every birthday beginning with the 105th. The tradition of Royal congratulations dates from 1908, when the Secretary for King Edward VII sent a congratulatory letter to Reverend Thomas Lord of Horncastle in a newspaper clipping, declaring, "I am commanded by the King to congratulate you on the attainment of your hundredth year, after a most useful life." The practice was formalised from 1917, under the reign of King George V, who also sent congratulations on the attainment of a 60th Wedding anniversary. Queen Elizabeth II sends a greeting card style with the notation: "I am so pleased to know that you are celebrating your one-hundredth birthday, I send my congratulations and best wishes to you on such a special occasion", thereafter each few years the card is updated with a current picture of the Queen to ensure people do not receive the same card more than once. The Queen further sends her congratulations on one's 105th birthday and every year thereafter as well as on special wedding anniversaries; people must apply for greetings three weeks before the event, on the official British Monarch's website.[63]

Centenarians born in Ireland receive a 2,540 "Centenarians' Bounty" and a letter from the President of Ireland, even if they are resident abroad.[64]

In the United States, centenarians traditionally receive a letter from the President, congratulating them for their longevity.

Japanese centenarians receive a silver cup and a certificate from the Prime Minister of Japan upon the Respect for the Aged Day following their 100th birthday, honouring them for their longevity and prosperity in their lives.[65][66][67]

An aspect of blessing in many cultures is to offer a wish that the recipient lives to 100 years old. Among Hindus, people who touch the feet of elders are often blessed with "May you live a hundred years". In Sweden, the traditional birthday song states, May he/she live for one hundred years. In Judaism, the term May you live to be 120 years old is a common blessing. In Poland, Sto lat, a wish to live a hundred years, is a traditional form of praise and good wishes, and the song "sto lat, sto lat" is sung on the occasion of the birthday celebrationsarguably, it is the most popular song in Poland and among Poles around the globe.

Chinese emperors were hailed to live ten thousand years, while empresses were hailed to live a thousand years. In Italy, "A hundred of these days!" (cento di questi giorni) is an augury for birthdays, to live to celebrate 100 more birthdays.[68] Some Italians say "Cent'anni!", which means "a hundred years", in that they wish that they could all live happily for a hundred years. In Greece, wishing someone Happy Birthday ends with the expression (na ta ekatostisis), which can be loosely translated as "may you make it one hundred birthdays".

While the number of centenarians per capita was much lower in ancient times than today, the data suggest that they were not unheard of. However, ancient demographics and chronicles are biased in favor of wealthy or powerful individuals rather than the ordinary person. A rare glimpse of an ordinary person is the legionary veteran Julius Valens whose tombstone states he lived 100 years - "VIXIT ANNIS C".[69] Grmek and Gourevitch speculate that during the Classical Greek period, anyone who lived past the age of five years surviving all the common childhood illnesses of that era had a reasonable chance of living to a relatively old age. Life expectancy in 400 BC was estimated to be around 30 years.[where?] One demographer of ancient civilizations reported that Greek men lived to 45 years on average (based on a sample size of 91), while women lived to 36.2 years (based on a sample size of 55). Notably, the gender statistics are inverted compared to today childbirth at the time had a far higher mortality rate than in modern times, skewing female statistics downward. It was common for average citizens to take great care in their hygiene, Mediterranean diet and exercise, although there was much more male trauma per capita than today, due to military service being virtually universal for citizens of Ancient Greece. This also biased the statistics for men downward.[70]

Diogenes Laertius (c. AD 250) gives one of the earliest references regarding the plausible centenarian longevity given by a scientist, the astronomer Hipparchus of Nicea (c. 185 c. 120 BC), who, according to the doxographer, assured that the philosopher Democritus of Abdera (c. 470/460 c. 370/360 BC) lived 109 years. All other ancient accounts of Democritus appear to agree that the philosopher lived at least 90 years. However, such longevity would not be dramatically out of line with that of other ancient Greek philosophers thought to have lived beyond the age of 90 (e.g. Xenophanes of Colophon, c. 570/565 c. 475/470 BC; Pyrrho of Ellis, c. 360 - c. 270 BC; Eratosthenes of Cirene c. 285 c. 190 BC). The case of Democritus differs from those of, for example, Epimenides of Crete (7th and 6th centuries BC), who is said to have lived an implausible 154, 157 or 290 years, depending on the source.

Numerous other historical figures were reputed to have lived past 100. The sixth dynasty Egyptian ruler Pepi II is believed by some Egyptologists to have lived to 100 or more (c. 2278 c. 2184 BC), as he is said to have reigned for 94 years.[71] However this is disputed: others say he only reigned 64 years.[72] Hosius of Crdoba, the man who convinced Constantine the Great to call the First Council of Nicaea, reportedly lived to age 102. The Chronicon of Bernold of Constance records the death in 1097 of Azzo marchio de Longobardia, pater Welfonis ducis de Baiowaria, commenting that he was iam maior centenario.[73] Ultimately, there is no reason to believe that centenarians did not exist in antiquity, even if they were not commonplace.[74]

Research in Italy suggests that healthy centenarians have high levels of both vitamin A and vitamin E and that this seems to be important in causing their extreme longevity.[75] Other research contradicts this, however, and has found that this theory does not apply to centenarians from Sardinia, for whom other factors probably play a more important role.[76] A preliminary study carried out in Poland showed that, in comparison with young healthy female adults, centenarians living in Upper Silesia had significantly higher red blood cell glutathione reductase and catalase activities, although serum levels of vitamin E were not significantly higher.[77] Researchers in Denmark have also found that centenarians exhibit a high activity of glutathione reductase in red blood cells. In this study, the centenarians having the best cognitive and physical functional capacity tended to have the highest activity of this enzyme.[78]

Other research has found that people whose parents became centenarians have an increased number of nave B cells. It is well known that the children of parents who have a long life are also likely to reach a healthy age, but it is not known why, although the inherited genes are probably important.[79] A variation in the gene FOXO3A is known to have a positive effect on the life expectancy of humans, and is found much more often in people living to 100 and beyond - moreover, this appears to be true worldwide.[80]

Men and women who are 100 or older tend to have extroverted personalities, according to Thomas T. Perls, the director of the New England Centenarian Study at Boston University. Centenarians will often have many friends, strong ties to relatives and high self-esteem. In addition, some research suggests that the offspring of centenarians are more likely to age in better cardiovascular health than their peers.[81]

Lymphoblastoid cell lines established from blood samples of centenarians have significantly higher activity of the DNA repair protein PARP (Poly ADP ribose polymerase) than cell lines from younger (20 to 70 years old) individuals.[82] The lymphocytic cells of centenarians have characteristics typical of cells from young people, both in their capability of priming the mechanism of repair after H2O2 sublethal oxidative DNA damage and in their PARP capacity.[83] PARP activity measured in the permeabilized mononuclear leukocyte blood cells of thirteen mammalian species correlated with maximum lifespan of the species.[84] These findings suggest that PARP mediated DNA repair activity contributes to the longevity of centenarians, consistent with the DNA damage theory of aging.[85]

Many experts attribute Japan's high life expectancy to the typical Japanese diet, which is particularly low in refined simple carbohydrates, and to hygienic practices. The number of centenarians in relation to the total population was, in September 2010, 114% higher in Shimane Prefecture than the national average. This ratio was also 92% higher in Okinawa Prefecture.[86][87][88] In Okinawa, studies have shown five factors that have contributed to the large number of centenarians in that region:[86]

Although these factors vary from those mentioned in the previous study, the culture of Okinawa has proven these factors to be important in its large population of centenarians.[86]

A historical study from Korea found that male eunuchs in the royal court had a centenarian rate of over 3%, and that eunuchs lived on average 14 to 19 years longer than uncastrated men.[89]

The number of Japanese centenarians was called into question in 2010, following a series of reports showing that hundreds of thousands of elderly people had gone "missing" in the country. The deaths of many centenarians had not been reported, casting doubt on the country's reputation for having a large population of centenarians.[90][91][92][93]

In July 2010, Sogen Kato, a centenarian listed as the oldest living male in Tokyo, registered to be aged 111, was found to have died some 30 years before; his body was found mummified in his bed,[94] resulting in a police investigation into centenarians listed over the age of 105. Soon after the discovery, the Japanese police found that at least 200 other Japanese centenarians were "missing", and began a nationwide search in early August 2010.[95]

By measuring the biological age of various tissues from centenarians, researchers may be able to identify tissues that are protected from aging effects. According to a study of 30 different body parts from centenarians and younger controls, the cerebellum is the youngest brain region (and probably body part) in centenarians (about 15 years younger than expected [96]) according to an epigenetic biomarker of tissue age known as epigenetic clock.[97]

These findings could explain why the cerebellum exhibits fewer neuropathological hallmarks of age related dementias compared to other brain regions. Further, the offspring of semi-supercentenarians (subjects who reached an age of 105109 years) have a lower epigenetic age than age-matched controls (age difference=5.1 years in peripheral blood mononuclear cells) and centenarians are younger (8.6 years) than expected based on their chronological age.[98]

Centenarians are often the subject of news stories, which often focus on the fact that they are over 100 years old. Along with the typical birthday celebrations, these reports provide researchers and cultural historians with evidence as to how the rest of society views this elderly population. Some examples:

Go here to see the original:
Centenarian - Wikipedia

Read More...

Beluga whale – Wikipedia

June 24th, 2018 7:42 am

The beluga whale or white whale (Delphinapterus leucas) is an Arctic and sub-Arctic cetacean. It is one of two members of the family Monodontidae, along with the narwhal, and the only member of the genus Delphinapterus. This marine mammal is commonly referred to as the beluga, melonhead, or sea canary due to its high-pitched twitter.

It is adapted to life in the Arctic, so has anatomical and physiological characteristics that differentiate it from other cetaceans. Amongst these are its all-white colour and the absence of a dorsal fin. It possesses a distinctive protuberance at the front of its head which houses an echolocation organ called the melon, which in this species is large and deformable. The beluga's body size is between that of a dolphin's and a true whale's, with males growing up to 5.5m (18ft) long and weighing up to 1,600kg (3,530lb). This whale has a stocky body. A large percentage of its weight is blubber, as is true of many cetaceans. Its sense of hearing is highly developed and its echolocation allows it to move about and find blowholes under sheet ice.

Belugas are gregarious and form groups of up to 10 animals on average, although during the summer, they can gather in the hundreds or even thousands in estuaries and shallow coastal areas. They are slow swimmers, but can dive to 700m (2,300ft) below the surface. They are opportunistic feeders and their diets vary according to their locations and the season. The majority of belugas live in the Arctic Ocean and the seas and coasts around North America, Russia and Greenland; their worldwide population is thought to number around 150,000. They are migratory and the majority of groups spend the winter around the Arctic ice cap; when the sea ice melts in summer, they move to warmer river estuaries and coastal areas. Some populations are sedentary and do not migrate over great distances during the year.

The native peoples of North America and Russia have hunted belugas for many centuries. They were also hunted commercially during the 19th century and part of the 20th century. Whale hunting has been under international control since 1973. Currently, only certain Inuit and Alaska Native groups are allowed to carry out subsistence hunting of belugas. Other threats include natural predators (polar bears and killer whales), contamination of rivers (as with PCBs which bioaccumulate up the food chain), and infectious diseases. From a conservation perspective, the beluga was placed on the International Union for Conservation of Nature's Red List in 2008 as being "near threatened"; the subpopulation from the Cook Inlet in Alaska, however, is considered critically endangered and is under the protection of the United States' Endangered Species Act. Of seven Canadian beluga populations, the two inhabiting eastern Hudson Bay and Ungava Bay are listed as endangered.

Belugas are one of the most commonly kept cetaceans in captivity and are housed in aquariums, dolphinariums, and wildlife parks in North America, Europe, and Asia. They are popular with the public due to their colour and expression.

The beluga was first described in 1776 by Peter Simon Pallas.[1] It is a member of the Monodontidae family, which is in turn part of the parvorder Odontoceti (toothed whales).[1] The Irrawaddy dolphin was once placed in the same family; recent genetic evidence suggests these dolphins belong to the family Delphinidae.[3][4] The narwhal is the only other species within the Monodontidae besides the beluga.[5] A skull has been discovered with intermediate characteristics supporting the hypothesis that hybridization is possible between these two families.[6]

The name of the genus, Delphinapterus, means "dolphin without fin" (from the Greek (delphin), dolphin and (apteros), without fin) and the species name leucas means "white" (from the Greek (leukas), white).[7] The Red List of Threatened Species gives both beluga and white whale as common names, though the former is now more popular. The English name comes from the Russian (belukha), which derives from the word (blyj), meaning "white".[7] The name beluga in Russian refers to an unrelated species, a fish, beluga sturgeon.

The whale is also colloquially known as the sea canary on account of its high-pitched squeaks, squeals, clucks, and whistles. A Japanese researcher says he taught a beluga to "talk" by using these sounds to identify three different objects, offering hope that humans may one day be able to communicate effectively with sea mammals.[8] A similar observation has been made by Canadian researchers, where a beluga which died in 2007 "talked" when he was still a subadult. Another example is NOC, a beluga whale that could mimic the rhythm and tone of human language. Beluga whales in the wild have been reported to imitate human voices.[9]

Mitochondrial DNA studies have shown modern cetaceans last shared a common ancestor between 30 and 34 million years ago.[10] The family Monodontidae separated relatively early from the other odontoceti; it split from the Delphinoidea between 11 and 15 million years ago, and from the Phocoenidae, its closest relatives in evolutionary terms, more recently still.[11] In 2017 the genome of a beluga whale was sequenced, comprising 2.327 Gbp of assembled genomic sequence that encoded 29,581 predicted genes.[12] The authors estimated that the genome-wide sequence similarity between beluga whales and killer whales to be 97.87% 2.4 107% (mean standard deviation).

The beluga's earliest known ancestor is the prehistoric Denebola brachycephala from the late Miocene period (910 million years ago).[13][14] A single fossil from the Baja California Peninsula indicates the family once inhabited warmer waters.[15] The fossil record also indicates, in comparatively recent times, the beluga's range varied with that of the polar ice packs expanding during ice ages and contracting when the ice retreated. Counter-evidence to this theory comes from the finding in 1849 of fossilised beluga bones in Vermont in the United States, 240km (150mi) from the Atlantic Ocean. The bones were discovered during construction of the first railroad between Rutland and Burlington in Vermont, when workers unearthed the bones of a mysterious animal in Charlotte. Buried nearly 10ft (3.0m) below the surface in a thick blue clay, these bones were unlike those of any animal previously discovered in Vermont. Experts identified the bones as those of a beluga. Because Charlotte is over 150mi (240km) from the nearest ocean, early naturalists were at a loss to explain the presence of the bones of a marine mammal buried beneath the fields of rural Vermont. The remains were found to be preserved in the sediments of the Champlain Sea, an extension of the Atlantic Ocean within the continent resulting from the rise in sea level at the end of the ice ages some 12,000 years ago.[17] Today, the Charlotte whale is the official Vermont State Fossil (making Vermont the only state whose official fossil is that of a still extant animal).[18]

Its body is round, particularly when well fed, and tapers less smoothly to the head than the tail. The sudden tapering to the base of its neck gives it the appearance of shoulders, unique among cetaceans. The tailfin grows and becomes increasingly and ornately curved as the animal ages. The flippers are broad and shortmaking them almost square-shaped.

Preliminary investigations suggested a beluga's life expectancy was rarely more than 30 years.[19] The method used to calculate the age of a beluga is based on counting the layers of dentin and dental cement in a specimen's teeth, which were originally thought to be deposited once or twice a year. The layers can be readily identified as one layer consists of opaque dense material and the other is transparent and less dense. It is therefore possible to estimate the age of the individual by extrapolating the number of layers identified and the estimated frequency with which the deposits are laid down.[20] A 2006 study using radiocarbon dating of the dentine layers showed the deposit of this material occurs with a lesser frequency (once per year) than was previously thought. The study therefore estimated belugas can live for 70 or 80 years.[21]

The species presents a moderate degree of sexual dimorphism, as the males are 25% longer than the females and are sturdier.[22] Adult male belugas can range from 3.5 to 5.5m (11 to 18ft), while the females measure 3 to 4.1m (9.8 to 13.5ft).[23] Males weigh between 1,100 and 1,600kg (2,430 and 3,530lb), occasionally up to 1,900kg (4,190lb) while females weigh between 700 and 1,200kg (1,540 and 2,650lb).[24][25] They rank as mid-sized species among toothed whales.[26]

Individuals of both sexes reach their maximum size by the time they are 10 years old.[27] The beluga's body shape is stocky and fusiform (cone-shaped with the point facing backwards), and they frequently have folds of fat, particularly along the ventral surface.[28] Between 40% and 50% of their body weight is fat, which is a higher proportion than for cetaceans that do not inhabit the Arctic, where fat only represents 30% of body weight.[29][30] The fat forms a layer that covers all of the body except the head, and it can be up to 15cm (5.9in) thick. It acts as insulation in waters with temperatures between 0 and 18C, as well as being an important reserve during periods without food.[31]

The adult beluga is rarely mistaken for any other species, because it is completely white or whitish-grey in colour.[32] Calves are usually born grey,[23] and by the time they are a month old, have turned dark grey or blue grey. They then start to progressively lose their pigmentation until they attain their distinctive white colouration, at the age of seven years in females and 9 in males.[32] The white colouration of the skin is an adaptation to life in the Arctic that allows belugas to camouflage themselves in the polar ice caps as protection against their main predators, polar bears and killer whales.[33] Unlike other cetaceans, the belugas seasonally shed their skin.[34] During the winter, the epidermis thickens and the skin can become yellowish, mainly on the back and fins. When they migrate to the estuaries during the summer, they rub themselves on the gravel of the riverbeds to remove the cutaneous covering.[34]

Like most toothed whales, it has a compartment found at the centre of the forehead that contains an organ used for echolocation called a melon, which contains fatty tissue.[35] The shape of the beluga's head is unlike that of any other cetacean, as the melon is extremely bulbous, lobed, and visible as a large frontal prominence.[35] Another distinctive characteristic it possesses is the melon is malleable; its shape is changed during the emission of sounds.[5] The beluga is able to change the shape of its head by blowing air around its sinuses to focus the emitted sounds.[36][37] This organ contains fatty acids, mainly isovaleric acid (60.1%) and long-chain branched acids (16.9%), a very different composition from its body fat, and which could play a role in its echolocation system.[38]

Unlike many dolphins and whales, the seven vertebrae in the neck are not fused together, allowing the animal to turn its head laterally without needing to rotate its body.[39] This gives the head a lateral manoeuvrability that allows an improved field of view and movement and helps in catching prey and evading predators in deep water.[33] The rostrum has about eight to 10 small, blunt, and slightly curved teeth on each side of the jaw and a total of 36 to 40 teeth.[40] Belugas do not use their teeth to chew, but for catching hold of their prey; they then tear them up and swallow them nearly whole.[41] Belugas only have a single spiracle, which is located on the top of the head behind the melon, and has a muscular covering, allowing it to be completely sealed. Under normal conditions, the spiracle is closed and an animal must contract the muscular covering to open the spiracle.[42] A beluga's thyroid gland is larger than that of terrestrial mammals weighing three times more than that of a horse which helps it to maintain a greater metabolism during the summer when it lives in river estuaries.[43] It is the marine cetacean that most frequently develops hyperplastic and neoplastic lesions of the thyroid.[44]

The fins retain the bony vestiges of the beluga's mammalian ancestors, and are firmly bound together by connective tissue.[28] The fins are small in relation to the size of the body, rounded and oar-shaped, and slightly curled at the tips.[7] These versatile extremities are mainly used as a rudder to control direction, to work in synchrony with the tailfin and for agile movement in shallow waters up to 3m (9.8ft) deep.[27] The fins also contain a mechanism for regulating body temperature, as the arteries feeding the fin's muscles are surrounded by veins that dilate or contract to gain or lose heat.[28][45] The tailfin is flat with two oar-like lobes, it does not have any bones, and is made up of hard, dense, fibrous connective tissue. The tailfin has a distinctive curvature along the lower edge.[28] The longitudinal muscles of the back provide the ascending and descending movement of the tailfin, which has a similar thermoregulation mechanism to the pectoral fins.[28]

Belugas have a dorsal ridge, rather than a dorsal fin.[23] The absence of the dorsal fin is reflected in the genus name of the speciesapterus the Greek word for "wingless". The evolutionary preference for a dorsal ridge rather than a fin is believed to be an adaptation to under-ice conditions, or possibly as a way of preserving heat.[5] The crest is hard and, along with the head, can be used to open holes in ice up to 8cm (3.1in) thick.[46]

The beluga has a very specialized sense of hearing and its auditory cortex is highly developed. It can hear sounds within the range of 1.2 to 120kHz, with the greatest sensitivity between 10 and 75kHz,[47] where the average hearing range for humans is 0.02 to 20kHz.[48] The majority of sounds are most probably received by the lower jaw and transmitted towards the middle ear. In the toothed whales, the lower jawbone is broad with a cavity at its base, which projects towards the place where it joins the cranium. A fatty deposit inside this small cavity connects to the middle ear.[49] Toothed whales also possess a small external auditory hole a few centimetres behind their eyes; each hole communicates with an external auditory conduit and an eardrum. It is not known if these organs are functional or simply vestigial.[49]

Belugas are able to see within and outside of water, but their vision is relatively poor when compared to dolphins.[50] Their eyes are especially adapted to seeing under water, although when they come into contact with the air, the crystalline lens and the cornea adjust to overcome the associated myopia (the range of vision under water is short).[50] A beluga's retina has cones and rods, which also suggests they can see in low light. The presence of cone cells indicates they can see colours, although this suggestion has not been confirmed.[50] Glands located in the medial corner of their eyes secrete an oily, gelatinous substance that lubricates the eye and helps flush out foreign bodies. This substance forms a film that protects the cornea and the conjunctiva from pathogenic organisms.[50]

Studies on captive animals show they seek frequent physical contact with other belugas.[33] Areas in the mouth have been found that could act as chemoreceptors for different tastes, and they can detect the presence of blood in water, which causes them to react immediately by displaying typical alarm behaviour.[33] Like the other toothed whales, their brains lack olfactory bulbs and olfactory nerves, which suggests they do not have a sense of smell.[35]

These cetaceans are highly sociable and they regularly form small groups, or pods, that may contain between two and 25 individuals, with an average of 10 members.[51] Pods tend to be unstable, meaning individuals tend to move from pod to pod. Radio tracking has even shown belugas can start out in one pod and within a few days be hundreds of miles away from that pod.[52] These pods contain animals of both sexes,[53] and are led by a dominant male.[40] Many hundreds and even thousands of individuals can be present when the pods join together in river estuaries during the summer. This can represent a significant proportion of the total population and is when they are most vulnerable to being hunted.[54]

They are cooperative animals and frequently hunt in coordinated groups.[55] The animals in a pod are very sociable and often chase each other as if they are playing or fighting, and they often rub against each other.[56]

In captivity, they can be seen to be constantly playing, vocalizing, and swimming around each other.[57] They show a great deal of curiosity towards humans and frequently approach the windows in the tanks to observe them.[58] Belugas may also playfully spit at humans or other whales. It is not unusual for an aquarium handler to be drenched by one of his charges. Some researchers believe spitting originated with blowing sand away from crustaceans at the sea bottom.

Belugas also show a great degree of curiosity towards humans in the wild, and frequently swim alongside boats.[59] They also play with objects they find in the water; in the wild, they do this with wood, plants, dead fish, and bubbles they have created.[29] During the breeding season, adults have been observed carrying objects such as plants, nets, and even the skeleton of a dead reindeer on their heads and backs.[57] Captive females have also been observed displaying this behaviour, carrying items such as floats and buoys, after they have lost a calf; experts consider this interaction with the objects could be acting as a substitute behaviour.[60]

Belugas are slower swimmers than the other toothed whales, such as the killer whale and the common bottlenose dolphin, because they are less hydrodynamic and have limited movement of their tailfins, which produce the greatest thrust.[61] They frequently swim at between 3 and 9km/h (1.9 and 5.6mph), although they are able to maintain a speed of 22km/h for up to 15 min.[40] Unlike most cetaceans, they are capable of swimming backwards.[27][62] Belugas swim on the surface between 5% and 10% of the time, while for the rest of the time they swim at a depth sufficient to cover their bodies.[27] They do not jump out of the water like dolphins or killer whales.[7]

These animals usually only dive to depths to 20m (66ft),[63] although they are capable of diving to greater depths. Individual captive animals have been recorded at depths between 400 and 647 m below sea level,[64] while animals in the wild have been recorded as diving to a depth of more than 700 m, with the greatest recorded depth being 872 m.[65] A dive normally lasts 3 to 5 min, but can last up to 18 min.[40][65][66] In the shallower water of the estuaries, a diving session may last around two minutes; the sequence consists of five or six rapid, shallow dives followed by a deeper dive lasting up to one minute.[27] The average number of dives per day varies between 31 and 51.[65]

All cetaceans, including belugas, have physiological adaptations designed to conserve oxygen while they are under water.[67] During a dive, these animals will reduce their heart rate from 100 beats a minute to between 12 and 20.[67] Blood flow is diverted away from certain tissues and organs and towards the brain, heart and lungs, which require a constant oxygen supply.[67] The amount of oxygen dissolved in the blood is 5.5%, which is greater than that found in land-based mammals and is similar to that of Weddell seals (a diving marine mammal). One study found a female beluga had 16.5 l of oxygen dissolved in her blood.[68] Lastly, the beluga's muscles contain high levels of the protein myoglobin, which stores oxygen in muscle. Myoglobin concentrations are several times greater than for terrestrial mammals, which help prevent oxygen deficiency during dives.[69]

Beluga whales often accompany bowhead whales, for curiosity and to secure polynya feasible to breathe as bowheads are capable of breaking through ice from underwater by headbutting.[70]

Belugas play an important role in the structure and function of marine resources in the Arctic Ocean, as they are the most abundant toothed whales in the region.[71] They are opportunistic feeders; their feeding habits depend on their locations and the season.[22] For example, when they are in the Beaufort Sea, they mainly eat Arctic cod (Boreogadus saida) and the stomachs of belugas caught near Greenland were found to contain rose fish (Sebastes marinus), Greenland halibut (Reinhardtius hippoglossoides), and northern shrimp (Pandalus borealis),[72] while in Alaska their staple diet is Pacific salmon (Oncorhynchus kisutch).[73] In general, the diets of these cetaceans consist mainly of fish; apart from those previously mentioned, other fish they feed on include capelin (Mallotus villosus), smelt, sole, flounder, herring, sculpin, and other types of salmon.[74] They also consume a great quantity of invertebrates, apart from shrimp, such as squid, crabs, clams, octopus, sea snails, bristle worms, and other deep-sea species.[74][75] Animals in captivity eat 2.5% to 3.0% of their body weight per day, which equates to 18.2 to 27.2kg.[76]

Foraging on the seabed typically takes place at depths between 20 and 40 m,[77] although they can dive to depths of 700 m in search of food.[65] Their flexible necks provide a wide range of movement while they are searching for food on the ocean floor. Some animals have been observed to suck up water and then forcefully expel it to uncover their prey hidden in the silt on the seabed.[55] As their teeth are neither large nor sharp, belugas must use suction to bring their prey into their mouths; it also means their prey has to be consumed whole, which in turn means it cannot be too large or the belugas run the risk of it getting stuck in their throats.[78] They also join together into coordinated groups of five or more to feed on shoals of fish by steering the fish into shallow water, where the belugas then attack them.[55] For example, in the estuary of the Amur River, where they mainly feed on salmon, groups of six or eight individuals join together to surround a shoal of fish and prevent their escape. Individuals then take turns feeding on the fish.[46]

Estimations of the age of sexual maturity for beluga whales vary considerably; the majority of authors estimate males reach sexual maturity when they are between four and seven years old, and females reach maturity when they are between four and nine years old.[79] The average age at which females first give birth is 8.5 years and fertility begins to decrease when they are 25, with no births recorded for females older than 41.[79]

Female belugas typically give birth to one calf every three years.[23] Most mating occurs usually February through May, but some mating occurs at other times of year.[5] The beluga may have delayed implantation.[5] Gestation has been estimated to last 12.0 to 14.5 months,[23] but information derived from captive females suggests a longer gestation period up to 475 days (15.8 months).[80]

Calves are born over a protracted period that varies by location. In the Canadian Arctic, calves are born between March and September, while in Hudson Bay, the peak calving period is in late June, and in Cumberland Sound, most calves are born from late July to early August.[81] Births usually take place in bays or estuaries where the water is warm with a temperature of 10 to 15C.[51] Newborns are about 1.5m (4.9ft) long, weigh about 80kg (180lb), and are grey in colour.[40] They are able to swim alongside their mothers immediately after birth.[82] The newborn calves nurse under water and initiate lactation a few hours after birth; thereafter, they feed at intervals around an hour.[55] Studies of captive females have indicated their milk composition varies between individuals and with the stage of lactation; it has an average content of 28% fat, 11% protein, 60.3% water, and less than 1% residual solids.[83] The milk contains about 92 cal per ounce.[84]

The calves remain dependent on their mothers for nursing for the first year, when their teeth appear.[51] After this, they start to supplement their diets with shrimp and small fish.[35] The majority of the calves continue nursing until they are 20 months old, although occasionally lactation can continue for more than two years,[40] and lactational anoestrus may not occur. Alloparenting (care by females different from the mother) has been observed in captive belugas, including spontaneous and long-term milk production. This suggests this behaviour, which is also seen in other mammals, may be present in belugas in the wild.[85]

Belugas use sounds and echolocation for movement, communication, to find breathing holes in the ice, and to hunt in dark or turbid waters.[36] They produce a rapid sequence of clicks that pass through the melon, which acts as an acoustic lens to focus the sounds into a beam that is projected forward through the surrounding water.[84] These sounds spread through the water at a speed of nearly 1.6km per second, some four times faster than the speed of sound in air. The sound waves reflect from objects and return as echoes that are heard and interpreted by the animal.[36] This enables them to determine the distance, speed, size, shape and the object's internal structure within the beam of sound. They use this ability when moving around thick Arctic ice sheets, to find areas of unfrozen water for breathing, or air pockets trapped under the ice.[51]

Some evidence indicates that belugas are highly sensitive to noise produced by humans. In one study, the maximum frequencies produced by an individual located in San Diego Bay, California, were between 40 and 60kHz. The same individual produced sounds with a maximum frequency of 100 to 120kHz when transferred to Kaneohe Bay in Hawaii. The difference in frequencies is thought to be a response to the difference in environmental noise in the two areas.[86]

These animals communicate using sounds of high frequency; their calls can sound like bird songs, so belugas were nicknamed "canaries of the sea".[87] Like the other toothed whales, belugas do not possess vocal cords and the sounds are probably produced by the movement of air between the nasal sacks, which are located near to the blowhole.[36]

Belugas are among the most vocal cetaceans.[88] They use their vocalisations for echolocation, during mating and for communication. They possess a large repertoire, emitting up to 11 different sounds, such as cackles, whistles, trills and squawks.[36] They make sounds by grinding their teeth or splashing, but they rarely use body language to make visual displays with their pectoral fins or tailfins, nor do they perform somersaults or jumps in the way other species do, such as dolphins.[36]

The beluga inhabits a discontinuous circumpolar distribution in Arctic and sub-Arctic waters.[89] During the summer, they can mainly be found in the deep waters ranging from 76N to 80N, particularly along the coasts of Alaska, northern Canada, western Greenland, and northern Russia.[89] The southernmost extent of their range includes isolated populations in the St. Lawrence River in the Atlantic,[90] and the Amur River delta, the Shantar Islands, and the waters surrounding Sakhalin Island in the Sea of Okhotsk.[91]

Belugas have a seasonal migratory pattern.[92] Migration patterns are passed from parents to offspring. Some travel as far as 6,000 kilometers per year.[93] When the summer sites become blocked with ice during the autumn, they move to spend the winter in the open sea alongside the pack ice or in areas covered with ice, surviving by using polynyas to surface and breathe.[94] In summer after the sheet ice has melted, they move to coastal areas with shallower water (13 m deep), although sometimes they migrate towards deeper waters (>800 m).[92] In the summer, they occupy estuaries and the waters of the continental shelf, and on occasion, they even swim up the rivers.[92] A number of incidents have been reported where groups or individuals have been found hundreds or even thousands of kilometres from the ocean.[95][96] One such example comes from 9 June 2006, when a young beluga carcass was found in the Tanana River near Fairbanks in central Alaska, nearly 1,700 kilometers (1,100mi) from the nearest ocean habitat. Belugas sometimes follow migrating fish, leading Alaska state biologist Tom Seaton to speculate it had followed migrating salmon up the river at some point in the previous autumn.[97] The rivers they most often travel up include: the Northern Dvina, the Mezen, the Pechora, the Ob and the Yenisei in Asia; the Yukon and the Kuskokwim in Alaska, and the Saint Lawrence in Canada.[89] Spending time in a river has been shown to stimulate an animal's metabolism and facilitates the seasonal renewal of the epidermal layer.[43] In addition, the rivers represent a safe haven for newborn calves where they will not be preyed upon by killer whales.[5] Calves often return to the same estuary as their mother in the summer, meeting her sometimes even after becoming fully mature.[98]

The migration season is relatively predictable, as it is basically determined by the amount of daylight and not by other variable physical or biological factors, such as the condition of the sea ice.[99] Vagrants may travel further south to areas such as Irish[100] and Scottish waters,[101] islands of Orkney[102] and Hebrides,[103] and to Japanese waters.[104] There had been several vagrant individuals [105] demonstrated seasonal residencies at Volcano Bay,[106][107][108] and a unique whale were used to return annually to areas adjacent to Shibetsu in Nemuro Strait in the 2000s.[109] On rarer occasions, individuals of vagrancy can reach the Korean Peninsula.[110] A few other individuals have been confirmed to return to the coasts of Hokkaido, and one particular individual became a resident in brackish waters of Lake Notoro since in 2014.[111][112]

Some populations are not migratory and certain resident groups will stay in well-defined areas, for example in Cook Inlet, the estuary of the Saint Lawrence River and Cumberland Sound.[113] The population in Cook Inlet stays in the waters furthest inside the inlet during the summer and until the end of autumn, then during the winter, they disperse to the deeper water in the centre of the inlet, but without completely leaving it.[114][115]

In April, the animals that spend the winter in the centre and southwest of the Bering Sea move to the north coast of Alaska and the east coast of Russia.[113] The populations living in the Ungava Bay and the eastern and western sides of Hudson Bay overwinter together beneath the sea ice in Hudson Strait. Whales in James Bay spend winter months within the basin could be a distinct group from these in Hudson Bay.[116] The populations of the White Sea, the Kara Sea and the Laptev Sea overwinter in the Barents Sea.[113] In the spring, the groups separate and migrate to their respective summer sites.[113]

Belugas exploit a varied range of habitats; they are most commonly seen in shallow waters close to the coast, but they have also been reported to live for extended periods in deeper water, where they feed and give birth to their young.[113]

In coastal areas, they can be found in coves, fjords, canals, bays, and shallow waters in the Arctic Ocean that are continuously lit by sunlight.[29] They are also often seen during the summer in river estuaries, where they feed, socialize, and give birth to young. These waters usually have a temperature between 8 and 10C.[29] The mudflats of Cook Inlet in Alaska are a popular location for these animals to spend the first few months of summer.[117] In the eastern Beaufort Sea, female belugas with their young and immature males prefer the open waters close to land; the adult males live in waters covered by ice near to the Canadian Arctic Archipelago, while the younger males and females with slightly older young can be found nearer to the ice shelf.[118] Generally, the use of different habitats in summer reflects differences in feeding habits, risk from predators, and reproductive factors for each of the subpopulations.[22]

The global beluga population is made up of a number of subpopulations. The scientific committee of the International Whaling Commission recognizes these 29 subpopulations:[2][22]

The estimate of population sizes is complicated because the boundaries for some of these groups overlap geographically or seasonally. The IUCN estimated the world beluga population in 2008 to be well in excess of 150,000.[2]

The native populations of the Canadian, Alaskan, and Russian Arctic regions hunt belugas for their meat, blubber, and skin. The cured skin is the only cetacean skin that is sufficiently thick to be used as leather.[119] Belugas were easy prey for hunters due to their predictable migration patterns and the high population density in estuaries and surrounding coastal areas during the summer.[119]

Commercial whaling by European and American whalers during the 18th and 19th centuries decreased beluga populations in the Canadian Arctic.[119] The animals were hunted for their meat and blubber, while the Europeans used the oil from the melon as a lubricant for clocks, machinery, and lighting in lighthouses.[119] Mineral oil replaced whale oil in the 1860s, but the hunting of these animals continued unabated. In 1863, the cured skin could be used to make horse harnesses, machine belts for saw mills, and shoelaces. These manufactured items ensured the hunting of belugas continued for the rest of the 19th century and the beginning of the 20th century.[120] Between 1868 and 1911, Scottish and American whalers killed more than 20,000 belugas in Lancaster Sound and Davis Strait.[119]

During the 1920s, fishermen in the Saint Lawrence River estuary considered belugas to be a threat to the fishing industry, as they eat large quantities of cod, salmon, tuna, and other fish caught by the local fishermen.[120] The presence of belugas in the estuary was, therefore, considered to be undesirable; in 1928, the Government of Quebec offered a reward of 15 dollars for each dead beluga.[121] The Quebec Department of Fisheries launched a study into the influence of these cetaceans on local fish populations in 1938. The unrestricted killing of belugas continued into the 1950s, when the supposed voracity of the belugas was found to be overestimated and did not adversely affect fish populations.[120] L'Isle-aux-Coudres is the setting for the classic 1963 National Film Board of Canada documentary Pour la suite du monde, which depicts a one-off resurrection of the beluga hunt.

The Arctic's native peoples still carry out subsistence hunting of belugas to obtain food and raw materials. This practice is a part of their culture, but doubts still remain whether the number of whales killed may be sustainable.[122] The number of animals killed is about 200 to 550 in Alaska and around 1,000 in Canada.[123] However, in areas such as Cook Inlet, Ungava Bay, and western Greenland, previous levels of commercial whaling have put the species in danger of extinction, and continued hunting by the native peoples may mean some populations will continue to decline.[122] The Canadian sites are the focus of discussions between the local communities and the Canadian government, with the objective of permitting sustainable hunting that does not put the species at risk of extinction.[124]

1970-99[126] 2013-15[127] 2000-2012[128]

2003-16[131]

1987-90 Cook Inlet[134] 1990-2011[135] 2012-2015 +Cook Inlet[136] [137]

During the winter, belugas commonly become trapped in the ice without being able to escape to open water, which may be several kilometres away.[138] Polar bears take particular advantage of these situations and are able to locate the belugas using their sense of smell. The bears swipe at the belugas and drag them onto the ice to eat them.[24] They are able to capture large individuals in this way; in one documented incident, a bear weighing between 150 and 180kg was able to capture an animal that weighed 935kg.[139]

Killer whales are able to capture both young and adult belugas.[24] They live in all the seas of the world and share the same habitat as belugas in the sub-Arctic region. Attacks on belugas by killer whales have been reported in the waters of Greenland, Russia, Canada, and Alaska.[140][141] A number of killings have been recorded in Cook Inlet, and experts are concerned the predation by killer whales will impede the recovery of this subpopulation, which has already been badly depleted by hunting.[140] The killer whales arrive at the beginning of August, but the belugas are occasionally able to hear their presence and evade them. The groups near to or under the sea ice have a degree of protection, as the killer whale's large dorsal fin, up to 2 m in length, impedes their movement under the ice and does not allow them to get sufficiently close to the breathing holes in the ice.[29]

The beluga is considered an excellent sentinel species (indicator of environment health and changes), because it is long-lived, at the top of the food web, bears large amounts of fat and blubber, relatively well-studied for a cetacean, and still somewhat common.

Human pollution can be a threat to belugas' health when they congregate in river estuaries. Chemical substances such as DDT and heavy metals such as lead, mercury and cadmium have been found in individuals of the Saint Lawrence River population.[142] Local beluga carcasses contain so many contaminants, they are treated as toxic waste.[143] Levels of polychlorinated biphenyls between 240 and 800 ppm have been found in belugas' brains, liver and muscles, with the highest levels found in males.[144] These levels are significantly greater than those found in Arctic populations.[145] These substances have a proven adverse effect on these cetaceans, as they cause cancers, reproductive diseases, and the deterioration of the immune system, making individuals more susceptible to pneumonias, ulcers, cysts, tumours, and bacterial infections.[145] Although the populations that inhabit the river estuaries run the greatest risk of contamination, high levels of zinc, cadmium, mercury, and selenium have also been found in the muscles, livers, and kidneys of animals that live in the open sea.[146]

From a sample of 129 beluga adults from the Saint Lawrence River examined between 1983 and 1999, a total of 27% had suffered cancer.[147] This is a higher percentage than that documented for other populations of this species and is much higher than for other cetaceans and for the majority of terrestrial mammals; in fact, the rate is only comparable to the levels found in humans and some domesticated animals.[147] For example, the rate of intestinal cancer in the sample is much higher than for humans. This condition is thought to be directly related to environmental contamination, in this case by polycyclic aromatic hydrocarbons, and coincides with the high incidence of this disease in humans residing in the area.[147] The prevalence of tumours suggests the contaminants identified in the animals that inhabit the estuary are having a direct carcinogenic effect or they are at least causing an immunological deterioration that is reducing the inhabitants' resistance to the disease.[148]

Indirect human disturbance may also be a threat. While some populations tolerate small boats, most actively try to avoid ships. Whale-watching has become a booming activity in the St. Lawrence and Churchill River areas, and acoustic contamination from this activity appears to have an effect on belugas. For example, a correlation appears to exist between the passage of belugas across the mouth of the Saguenay River, which has decreased by 60%, and the increase in the use of recreational motorboats in the area.[149] A dramatic decrease has also been recorded in the number of calls between animals (decreasing from 3.4 to 10.5 calls/min to 0 or <1) after exposure to the noise produced by ships, the effect being most persistent and pronounced with larger ships such as ferries than with smaller boats.[150] Belugas can detect the presence of large ships (for example icebreakers) up to 50km away, and they move rapidly in the opposite direction or perpendicular to the ship following the edge of the sea ice for distances of up to 80km to avoid them. The presence of shipping produces avoidance behaviour, causing deeper dives for feeding, the break-up of groups, and asynchrony in dives.[151]

As with any animal population, a number of pathogens cause death and disease in belugas, including viruses, bacteria, protozoans, and fungi, which mainly cause skin, intestinal, and respiratory infections.[152]

Papillomaviruses have been found in the stomachs of belugas in the Saint Lawrence River. Animals in this location have also been recorded as suffering infections caused by herpesviruses and in certain cases to be suffering from encephalitis caused by the protozoan Sarcocystis. Cases have been recorded of ciliate protozoa colonising the spiracle of certain individuals, but they are not thought to be pathogens or are not very harmful.[153]:26, 303, 359

The bacterium Erysipelothrix rhusiopathiae, which probably comes from eating infected fish, poses a threat to belugas kept in captivity, causing anorexia and dermal plaques and lesions that can lead to septicemia.[153]:26, 303, 359 This condition can cause death if it is not diagnosed and treated in time with antibiotics such as ciprofloxacin.[154][153][153]:3167

A study of infections caused by parasitic worms in a number of individuals of both sexes found the presence of larvae from a species from the genus Contracaecum in their stomachs and intestines, Anisakis simplex in their stomachs, Pharurus pallasii in their ear canals, Hadwenius seymouri in their intestines, and Leucasiella arctica in their rectums.[155]

Belugas were among the first whale species to be kept in captivity. The first beluga was shown at Barnum's Museum in New York City in 1861.[156] For most of the 20th century, Canada was the predominant source for belugas destined for exhibition. Until the early 1960s, they were taken from the St. Lawrence River estuary (famously captured in the film documentary Pour la suite du monde) and from 1967 from the Churchill River estuary. This continued until 1992, when the practice was banned.[157] Since Canada ceased to be the supplier of these animals, Russia has become the largest provider.[157] Individuals are caught in the Amur River delta and the far eastern seas of the country, and then are either transported domestically to aquaria in Moscow, St. Petersburg, and Sochi, or exported to foreign nations, including Canada.[157]

Today, it remains one of the few whale species kept at aquaria and marine parks across North America, Europe, and Asia.[157] As of 2006, 30 belugas were in Canada and 28 in the United States, and 42 deaths in captivity had been reported up to that time.[157] A single specimen can reportedly fetch up to US$100,000 on the market. The beluga's popularity with visitors reflects its attractive colour and its range of facial expressions. The latter is possible because while most cetacean "smiles" are fixed, the extra movement afforded by the beluga's unfused cervical vertebrae allows a greater range of apparent expression.[39]

To provide some enrichment while in captivity, aquaria train belugas to perform behaviours for the public[158] and for medical exams, such as blood draws[159] and ultrasound,[160] provide toys,[158] and allow the public to play recorded or live music.[161]

Most belugas found in aquaria are caught in the wild, as captive-breeding programs have not had much success so far.[162] For example, despite best efforts, as of 2010, only two male whales had been successfully used as stud animals in the Association of Zoos and Aquariums beluga population, Nanuq at SeaWorld San Diego and Naluark at the Shedd Aquarium in Chicago, USA. Nanuq has fathered 10 calves, five of which survived birth.[163] Naluark at Shedd Aquarium has fathered four living offspring.[164] Naluark has been relocated to the Mystic Aquarium in the hope that he will breed with two of their females.[165] The first beluga calf born in captivity in Europe was born in L'Oceanogrfic marine park in Valencia, Spain, in November 2006.[166] However, the calf died 25 days later after suffering metabolic complications, infections, and not being able to feed properly.[167] A second calf was born in November, 16th 2016, and was successfully maintained by artificial feeding based on enriched milk.[168]

Between 1960 and 1992, the United States Navy carried out a program that included the study of marine mammals' abilities with echolocation, with the objective of improving the detection of underwater objects. The program started with dolphins, but a large number of belugas were also used from 1975 on.[169] The program included training these mammals to carry equipment and material to divers working under water, the location of lost objects, surveillance of ships and submarines, and underwater monitoring using cameras held in their mouths.[169] A similar program was implemented by the Russian Navy during the Cold War, in which belugas were also trained for antimining operations in Arctic waters.[142]

In 2009 during a free-diving competition in a tank of icy water in Harbin, China, a captive beluga brought a cramp-paralyzed diver from the bottom of the pool up to the surface by holding her foot in its mouth, saving the diver's life.[170][171]

Films which have publicized issues of beluga welfare include Born to Be Free,[172] Sonic Sea,[173] and Vancouver Aquarium Uncovered.[174]

Whale watching has become an important activity in the recovery of the economies of towns in Hudson Bay near to the Saint Lawrence and Churchill Rivers. The best time to see belugas is during the summer, when they meet in large numbers in the estuaries of the rivers and in their summer habitats.[175] The animals are easily seen due to their high numbers and their curiosity regarding the presence of humans.[175]

However, the boats' presence poses a threat to the animals, as it distracts them from important activities such as feeding, social interaction and reproduction. In addition, the noise produced by the motors has an adverse effect on their auditory function and reduces their ability to detect their prey, communicate, and navigate.[176] To protect these marine animals during whale-watching activities, the US National Oceanic and Atmospheric Administration has published a Guide for observing marine life. The guide recommends boats carrying the whale watchers keep their distance from the cetaceans and it expressly prohibits chasing, harassing, obstructing, touching, or feeding them.[177]

Some regular migrations do occur into Russian EEZ of Sea of Japan such as to Rudnaya Bay, where diving with wild belugas became a less-known but popular attraction.[178]

Male belugas in captivity can mimic the pattern of human speech, several octaves lower than typical whale calls. It is not the first time a beluga has been known to sound human, and they often shout like children, in the wild.[179] One captive beluga, after overhearing divers using an underwater communication system, caused one of the divers to surface by imitating their order to get out of the water. Subsequent recordings confirmed that the beluga had become skilled at imitating the patterns and frequency of human speech. After several years, this beluga ceased making these sounds.[180]

Prior to 2008, the beluga was listed as "vulnerable" by the International Union for Conservation of Nature (IUCN), a higher level of concern. The IUCN cited the stability of the largest subpopulations and improved census methods that indicate a larger population than previously estimated. In 2008, the beluga was reclassified as "near threatened" by the IUCN due to uncertainty about threats to their numbers and the number of belugas over parts of its range (especially the Russian Arctic), and the expectation that if current conservation efforts cease, especially hunting management, the beluga population is likely to qualify for "threatened" status within five years.[181] In June 2017, its status was reassessed to "least concern".[2]

Subpopulations are subject to differing levels of threat and warrant individual assessment. The nonmigratory Cook Inlet subpopulation is listed as "Critically Endangered" by the IUCN as of 2006[2] and is listed as Endangered under the Endangered Species Act as of October 2008.[182][183][184] This was due to overharvesting of belugas prior to 1998. The population has failed to recover, though the reported harvest has been small. The most recently published estimate as of May 2008 was 302 (CV=0.16) in 2006.[2] In addition, the National Marine Fisheries Service indicated the 2007 aerial survey's point estimate was 375.

The US Congress passed the Marine Mammal Protection Act of 1972 outlawing the persecution and hunting of all marine mammals within US coastal waters. The act has been amended a number of times to permit subsistence hunting by native peoples, temporary capture of restricted numbers for research, education and public display, and to decriminalise the accidental capture of individuals during fishing operations.[185] The act also states that all whales in US territorial waters are under the jurisdiction of the National Marine Fisheries Service, a division of NOAA.[185]

To prevent hunting, belugas are protected under the 1986 International Moratorium on Commercial Whaling; however, hunting of small numbers of belugas is still allowed. Since it is very difficult to know the exact population of belugas because their habitats include inland waters away from the ocean, they easily come in contact with oil and gas development centres. To prevent whales from coming in contact with industrial waste, the Alaskan and Canadian governments are relocating sites where whales and waste come in contact.

The beluga whale is listed on appendix II[186] of the Convention on the Conservation of Migratory Species of Wild Animals (CMS). It is listed on Appendix II[186] as it has an unfavourable conservation status or would benefit significantly from international co-operation organised by tailored agreements. All toothed whales are protected under the CITES that was signed in 1973 to regulate the commercial exploitation of certain species.[187]

The isolated beluga population in the Saint Lawrence River has been legally protected since 1983.[188] In 1988 Canadian Department of Fisheries and Oceans and Environment Canada, a governmental agency that supervises national parks, implemented the Saint Lawrence Action Plan[189] with the aim of reducing industrial contamination by 90% by 1993; as of 1992, the emissions had been reduced by 59%.[122] The population of the St. Lawrence belugas decreased from 10,000 in 1885 to around 1,000 in the 1980 and around 900 in 2012.[190]

Pour la suite du monde, is a Canadian documentary film released in 1963 about traditional beluga hunting carried out by the inhabitants of L'Isle-aux-Coudres on the Saint Lawrence River.[191]

White Whale Records was an American record company that operated between 1965 and 1971 in Los Angeles, California, it was the record company of The Turtles. The company's logo was the silhouette of a beluga with the words "White Whale" above it.[192]

The children's singer Raffi released an album called Baby Beluga in 1980. The album starts with the sound of whales communicating, and includes songs representing the ocean and whales playing. The song "Baby Beluga" was composed after Raffi saw a recently born beluga calf in Vancouver Aquarium.[193]

Yamaha's Beluga motorcycle (Riva 80/CV80) which had an 80-cc engine was produced from 1981 until 1987 and sold throughout the world, particularly in Canada, the USA, the Netherlands, Belgium, Sweden, and Japan.[194]

The Beluga class submarine (project 1710 Mackerel) was an experimental Russian submarine whose prototype operated until 1997, with the whole project being discontinued in the mid-2000s.[195]

The fuselage design of the Airbus Beluga, one of the world's biggest cargo planes, is very similar to that of a beluga; it was originally called the Super Transporter, but the nickname Beluga became more popular and was then officially adopted.[196]

The German company SkySails GmbH & Co. KG, a subsidiary of the Beluga Shipping group based in Hamburg, tested a new propulsion system for ships that involved a large wing similar to that used in paragliding and which has demonstrated a reduction in fuel use between 10% and 35%. The programme to prove the efficiency of the system was called Project Beluga, as it involved the ship MS Beluga Skysails. The company's insignia, a beluga's tailfin, was printed on the giant wing, which had a surface area of 160m2.[197]

A 2002 episode of science fiction series Dark Angel titled "Dawg Day Afternoon" claims that beluga whales are the result of a hybridisation between a humpback whale and a dolphin.

In the Disney/Pixar film Finding Dory, (a sequel to Finding Nemo) the character Bailey is a beluga whale.[198]

View original post here:
Beluga whale - Wikipedia

Read More...

NewVisionClinics – Specialist Eye Surgeons For Melbourne

June 24th, 2018 7:40 am

NewVision Clinics provide expert ophthalmologist services in Melbourne, making it convenient for everyone to consult an eye specialist. We pride ourselves on using the latest technology, combined with the most modern procedures, ensuring the highest standards of vision correction for all of our clients.

NewVision Cllinics is a full service ophthalmological provider. We specialise in laser eye surgery and support both LASIK and Advanced PRK techniques using the process of Lasersight. Our principal Professor Noel Alpins is recognised around the globe as a leading authority in corrective laser eye surgery with a special interest in astigmatism, you can rest assured you have chosen a professional clinic that is leading the way in Australia.

Throughout our website you will find many useful resources, each designed to help you understand the process. We make sure our patients fully understand what is involved with the procedure required by providing professional advice in a relaxed environment.

If you feel your vision is deteriorating, you want to reduce the need for glasses or contact lenses, or have any concerns regarding your eyesight, contact us today. We provide a no-cost, no-obligation assessment, tailoring the best solution to your individual requirements

Talk to one of our helpful and friendly staff today and discover more about our full range of services. We can book you in for assessment with our team and put you on the road to better eye sight. Call us on1800 20 20 20and we will be happy to discuss your situation and book a consultation that suits your schedule.

About us

Visit link:
NewVisionClinics - Specialist Eye Surgeons For Melbourne

Read More...

Health and Wellness : Personalized Medicine

June 23rd, 2018 5:46 pm

Personalized medicine relies on tests to help determine an individuals response to certain medications.

Personalized medicine takes into account your unique genetic makeup. Unlike "genetic medicine," which is directed at such inherited diseases as sickle cell anemia, personalized medicine can help your doctor tailor treatment for conditions such as heart disease and deep vein thrombosis. This enables him/her to focus on prevention, detection and early intervention.

Your genetic makeup also affects which medicines work best for youand how you respond to them. Your doctor can prescribe targeted treatment based on both:

We offer two such tests, which represent the forefront of personalized medicine. They can determine your response to two of the most widely prescribed drugs.

Marketed as Coumadin and Jantoven, warfarin thins the blood to help prevent and treat deep vein thrombosis, stroke, heart attack, atrial fibrillation and other diseases of the arteries and veins. The right dosage is crucial. Too low a dose could increase the risk of a life-threatening blood clot. Too high a dose could increase bleeding risk. Plus, your response to a specific dose can vary widely. We offer the AccuType Warfarin test to help your physician determine the appropriate dosage based on your genetic information.

Marketed as Plavix, clopidogrel is another blood thinner. The AccuType CP test identifies if youre unlikely to respond well to the drug and therefore at increased risk for stroke or heart attack. It also identifies if youre likely to be overly sensitive to the drug and therefore at increased risk for bleeding episodes.

Personalized medicine, including these two laboratory tests, can help make possible:

The rest is here:
Health and Wellness : Personalized Medicine

Read More...

Page 930«..1020..929930931932..940950..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick